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Abstract 
Hydrophilic matrices are widely used in the pharmaceutical industry as control release agents in solid oral 
dosage formulations. One of the key parameters that controls release in such systems is the distribution of 
exipients within the formulation, which in turn is governed by the processing and manufacturing 
procedures. This thesis explores the effect of processing on the distribution of excipients in binary and 
tertiary formulations obtained using different mixing procedures, (manual shaking, tumble blending and 
grinding) with a range of particle size distributions. Samples were prepared by compacting processed 
powder mixtures directly onto a diamond attenuated total reflectance (ATR) crystal using an in-house built 
compaction cell which proved to be a successful tool for small scale tablet manufacturing. For this study 
the following exipients were used; the hydrophilic matrix HPMC grade K4M, the drug 6-hydroxy 
buspirone hydrochloride and citric acid. The homogeneity of the formulations were determined by the 
reproducibility of the spectra obtained from the tablets after compaction and the concentration of exipients 
within the samples was successfully predicted using Partial Least Squares (PLS) data analysis. The 
distribution of the components was confirmed using Near Infrared imaging with principal components 
analysis (PCA). Standard dissolution tests of the binary and tertiary systems gave an indication about the 
release behaviour of the formulations in different dissolution media. Total dissolution of the drug was 
observed in 0.1N HCl for binary mixtures and in both pH 6.8 buffer and 0.1 N HCl for tertiary formulations 
highlighting the impact of citric acid on the dissolution results and confirming the pH dependence of the 
system. The release of drug was also studied using the complementary technique of ATR-FTIR by 
performing hydration experiments on the compacted tablets. Both standard data analysis approaches, such 
as peak area changes, and multivariate curve resolution (MCR) were applied to these datasets. The MCR 
studies showed some promise, but also highlighted a need for further development. The standard data 
analysis showed that the rate of release of the API and citric acid was higher than the rate of solvation of 
HPMC, indicating a diffusion controlled release mechanism. Standard dissolution experiments and infrared 
spectroscopy measurements were combined, by developing a hyphenated system, whereby dissolution 
media was circulated through the ATR compaction cell and out through a UV/vis flow detector in a closed 
loop. These results were in good agreement with the data from both the standard dissolution tests and the 
ATR-FTIR hydration studies. 
List of Abbreviations: 
ATR                attenuated total reflectance 
API                 active pharmaceutical ingredient 
BMS               Bristol Myers-Squibb 
BP                   buspirone hydrochloride 
6OHBP           6-hydroxy buspirone hydrochloride 
CA                   citric acid 
cm
-1
                wavenumber 
DS                  degree of substitution 
EHEC             ethylhydroxyethylcellulose 
FCC USP        food chemical codex U.S.Pharmacopeia 
FTIR               Fourier transformed infrared 
HEC                hydroxyethylcellulose 
HEMC            hydroxyethylmethylcellulose 
HPC                hydroxypropylcellulose 
HPMC            hydroxypropylmethylcellulose 
MC                 methylcellulose 
MCR              multivariate curve resolution 
MS                 molar substitution 
NaCMC          sodium carboxymethylcellulose 
nm                   nanometer 
PCA                principal component analysis 
PLS                 partial least squares  
RMSECV        root-mean-square error of cross-validation 
USP H VISC  US Pharmacopeia high viscosity 
UV                  ultraviolet 
w
/w                            weight in weight 
μm                   micrometer 
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1. Introduction  
Compressed powder mixtures of one or more hydrophilic polymers with water swelling 
properties, drug and excipients are called hydrophilic matrices. The ability of hydrophilic 
polymer matrix systems to provide a desirable drug release profile, cost effectiveness and 
also broad acceptance of U.S. Food and Drug Administration (FDA) makes them one of the 
most widely used type of matrices in a controlled release formulation [1, 2]. One of the 
most commonly used hydrophilic polymers for pharmaceutical formulations is 
hydroxypropyl methylcellulose (HPMC).  This polymer, due to its non toxic nature, non pH 
dependence and ability to accommodate a large percentage of the drug, fulfills the 
requirements proposed by the Pifferi and Restani of the modern pharmaceutical excipient 
[3]. Moreover the ability to hydrate rapidly when in contact with liquid water to form a 
protective gel around the tablet matrix is an essential HPMC property for drug release   
[4, 5]. 
 
In this introduction the drug release mechanism from hydrophilic matrices along with the 
properties of hydroxypropyl methylcellulose (HPMC), one of the cellulose derivatives, are 
discussed, focusing on the use of HPMC as an extended release polymer.  Also the factors 
influencing the drug release and possible modifications of this process by incorporating pH 
modifiers into the formulation are included. 
Finally, the aims of the thesis will be addressed. 
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1.1  Properties of HPMC  
 
Cellulose is a linear polymer consisting of anhydroglucose units joined by β 1-4 glycosidic 
linkages. The substance is insoluble in water due to the presence of inter- and 
intramolecular hydrogen bonding between hydroxyl groups and the glucose ring oxygen, 
which influences the high degree of crystallinity. Cellulose contains three reactive hydroxyl 
groups, two secondary and one primary at the position C-2, C-3 and C-6 atoms on each 
AGU unit [6, 7].  
 
 
 
                                                                                                                      
                                          R = H, CH3, CH2CH(OH)CH3 
Fig.1-1 Structure of hydroxypropylmethylcellulose 
Hydroxypropyl methylcellulose (also called hypromellose) is mixed cellulose ether, 
containing hydroxypropyl and methoxyl groups in anhydroglucose unit (AGU), which is 
the basic repeating structure of cellulose. Production of HPMC involves heating cellulose 
fibres with sodium hydroxide solution to break inter- and intra-molecular hydrogen 
bonding (mercerisation process). The disrupted polymer has the ability to swell in water 
which allows reactants to penetrate and later to start the substitution process. Adding 
methyl chloride and propylene oxide to the alkali cellulose created in the mercerisation 
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process, leads to the hydroxypropyl and methyl substitution of anhydroglucose units. The 
hydroxypropyl and methyl substitution can be controlled by the weight ratio and 
concentration of added reagents during the production process [8, 9]. The ratios of those 
two substituents give the hypromellose different characteristics.  The average number of 
hydroxyl groups per AGU unit where hydrogen atom is replaced by methyl is defined as 
degree of substitution (DS), whilst the term molar substitution (MS) is used to described the 
average number of moles of propylene oxide per anhydroglucose unit [10, 11]. Viscosity is 
typically given as a mean, or as a range due to viscometer acceptable ranges of error and 
the results of various test methods and viscometers which do not necessarily correspond to 
each other. The pharmaceutically important grades of HPMC are classified in United States 
Pharmacopeia (USP) according to the hydroxypropyl and methoxy group content.  
Dow HPMC grades (Methocel
TM
) use in pharmaceuticals 
Methocel
TM
 
grade 
USP type Methoxy 
[%] 
Methoxy 
(DS) 
Hydroxypropyl 
[%] 
Hydroxypropyl 
(MS) 
Viscosity 
[cps] 
J 1828 16.5 - 20 0.93 – 1.15 23 – 32 0.61 – 0.91 5000 -
75000 
E 2910 28 - 30 1.65 – 1.9 7 – 12 0.2 – 0.3 5 – 4000 
F 2906 27 – 30 1.6 – 1.8 4 – 7.5 0.1 - 0.2 50 – 4000 
K 2208 19 - 24 1.1 – 1.4 4 - 12 0.1 – 0.3 35 - 100000 
Table1-1. Grades of HPMC [12, 13]      
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1.1.1. Solubility 
The physical properties of cellulose ethers depend on the uniformity, amount and type of 
the substituent groups. The methylcellulose dissolves readily in the cold water at 1.3-2.6 
DS, whilst in polar organic solvents from about 2 DS. The presence of hydroxypropyl 
substitution gives the solubility in cold water at 1.5 DS, in the case of hydroxyalkyl 
cellulose derivatives the minimum starts at 0.65 for HEC. The rates of aqueous medium 
absorption by cellulose tablet matrix may affect the drug release profile. The water soluble 
cellulose derivatives depending on the substitution shows varied hydrophilicity. Depending 
on DS and MS values the derivatives shows increasing hygroscopicity in order: 
HPC<MC~HEMC~HPMC~EHEC<HEC<<NaCMC [14, 15] 
 
1.1.2 Thermal gelation 
 
Solutions of most nonionic cellulose ethers show ‘’reversible thermal gelation’’, that is the 
ability to form the structured gel upon heating (due to dehydration of polymer) and gelation 
is reversible upon cooling. Gelation of HPMC is thought to arise from hydrophobic 
interactions between the methoxyl substitutions of the polymer. Sakar has defined HPMC 
gel as an intermediate, non-equilibrium metastable state where this three dimensional 
network structure is formed due to the secondary valence forces [16].  The inverse 
solubility-temperature behaviour of HPMC was observed in the case within the narrow 
temperature range and as a result the cross-linking by covalent bonding is unlikely. Cross-
links may be formed as a result of hydrogen or hydrophobic bonds as the solvent power of 
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the medium decreases [16]. The gelation temperature indicates the hydrophilicity of the 
cellulose ether and depends on the substitution type and amounts of substituents groups and 
their distribution. The presence of hydroxyalkyl groups leads to the higher gel point 
temperatures as these derivatives are more soluble in water, whilst highly substituted 
molecules have lower gel point temperatures. The gel temperature depends also on the 
concentration of the substance in a solution, presence of other materials in the solution, for 
e.g inorganic salts or particular organic additives (sorbitol, glycerol) which can depress the 
gel point. In addition substances that are good solvents for the polymer (propyleneglycol) 
are able to increase the gel point [14, 16-18].     
 
1.1.3.Viscosity 
 
The viscosity of HPMC solutions increases as the concentration of the polymer increases. 
Viscosity values for cellulose ether solutions are quoted for 2% w/w concentrations  
at 20 
o C. The Philipoff’s equation describes the relationship between viscosity and 
concentration of the cellulose ethers, where the eighth root of the apparent viscosity is 
linearly related to the concentration: 



0
8
1
8
 






[ ]c
    (eq.1.1) 
Where: η – the apparent viscosity, η0 – the solvent viscosity, [η] – intrinsic viscosity, c- the 
concentration of the polymer.   
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The viscosity of the solution depends on the molecular weight grade and on the type and 
amount of substituent groups. The apparent viscosity of the polymeric solutions can also be 
affected by the additives and temperature. The viscosity of the cellulose ethers solutions 
decreases with the increasing temperature. Presence of some electrolytes in the solution 
reduces the viscosity below the gelation temperature [14, 19, 20].  
 
1.1.4.Surface activity 
The active surface of the HPMC polymer is the result of the ability of solute molecules to 
alter the attractive interactions between two dissimilar molecules (air-water or oil-water) at 
the interface. This property can be attributed to the presence of alkyl (hydrophobic) and 
hydroxyl (hydrophilic) groups along the cellulose backbone. Surfactant molecules are able 
to reduce the surface/interfacial tension as their hydrophilic and lipophilic ends of each 
molecule are oriented into each phase. The maximized interactions of water and oil 
molecules at the interface result in the lowered interfacial tension. Surface activity is 
increased with the raise of the temperature until the gelation temperature is reached. The 
concentration of HPMC in such solution was found to have little effect on surface activity 
[21-23]. 
 
1.1.5 Influence of polymer on the drug release.  
Since diffusion plays a prominent role in controlling drug release, the release kinetics 
constantly changes because of the changing diffusional path length. Escudero studied the 
possibility of modulation of theophylline release by mixing HPMC of different viscosity 
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grades and a new generation of copolymers [24]. It was found that the degree of 
substitution of HPMC used may also influence drug release characteristics.  
Another factor that has an influence on the rate of drug release is the particle size of the 
polymer in the formulation. There is a lot of work published concerning the impact of 
HPMC particle size in formulation of release rates. In the case of water-soluble drugs, the 
effect of particle size on the release rate was visible with a low dose of HPMC in a tablet 
and large particle size of the drug [25-29]. 
It has been proposed that the drug:polymer concentration ratio (increasing drug 
concentration) is the most influential variable controlling the drug release. The reduction of 
the drug release rate from the tablets has been attributed to the reduced erosion of the gel 
layer and the increase of the drug diffusion pathlength and tortuosity [27, 28, 30].   
The degree and ratio of the methoxyl and hydroxypropyl substitution determines the 
physico-chemical characteristics of different HPMC types. The hydrophobic methoxy 
groups decrease the capability of the polymer chains to form hydrogen bonding, 
influencing the interactions with water. The HPMC type effects the tensile strength of 
matrices, hydration rates of the polymer and drug release. However, when a certain 
polymer content has been reached (30-40%) the HPMC substitution degree has less 
significance and similar drug profiles can be obtained.  
The infrared spectrum of HPMC (Fig. 1-2) shows the presence of a strong characteristic 
vibration band at ~1100 cm
-1
 ν(CO). In the region ~3570-3200 cm-1 ν(OH), the bands are 
associated with the presence of hydroxyl groups from the polymer and also the band  
 ν (CH) 2800-3000 cm-1 is present [31, 32]. 
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Fig 1-2. FTIR spectrum of pure HPMC. 
 
1.1.6 Applications of cellulose ethers 
Cellulose compounds are widely used in the pharmaceutical industry as tablet binders, 
thickeners, suspending agents, emulsifiers, film builders, bioadhesive materials and tablet 
matrices for controlled release applications [14, 33]. Cellulose ethers are also employed in 
many different industries with many applications owing mainly to their solution properties. 
Some examples include: adhesives, agricultural applications, ceramics, constructions and 
cosmetics [11, 29].  
 
Wollenweber noted that the emulsion stabilizing activity of HPMC, leads to the extended 
use of this polymer in food, cosmetics and pharmaceutical industry as the result of its 
surface active nature [20].  
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1.2 Influence of active substance on the drug release from 
hydrophilic matrices. 
 
The physicochemical properties of the active substance in a formulation have substantial 
effect on the nature of drug release. Aqueous solubility of the active substance is an 
important factor which influences release, transport and absorption of the drug in the body. 
In general, the drug release mechanism of soluble active pharmaceutical ingredient (API) 
from HPMC matrices is considered to follow a Fickian diffusion process. In the case of 
poorly soluble drugs the release by gel layer erosion is generally observed. Eyjolfsson 
(1999) investigated release kinetics of a practically water insoluble model drug 
incorporated in two types of HPMC (K4M and K100LV). The non-Fickian behavior of 
drug release was reported [34, 35].  
Subsequently, a range of drug release rates and release mechanism changes have been 
characterized after incorporation in hydrophilic matrices (HPMC and HPC), for APIs with 
varying drug solubility. Freely soluble diclofenac sodium showed the highest and fastest 
release in pH 6.5 phosphate buffer followed by ibuprofen and naproxen with medium 
solubility and practically insoluble indomethacin which gave the slowest release [36].   
During studies on the release mechanism of API’s with different solubility from swelling 
matrices (HPMC), Colombo (2001) [66] showed that the rate and amount of drug released 
was dependent on the active substance dissolution and diffusion rates, and but also from the 
“drug particle translocation” process. In the case of low solubility drugs the solid particles 
of active substance were transported from the swelling front of the matrices to the eroding 
front of the gel layer. The particle displacement process was explained as a result of the 
spring-like action of macromolecular chains upon transition from glassy to rubbery state of 
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the polymer. The expansion of the polymer chains by relaxation led to movement of 
dissolved drug. The release mechanism continued to be a diffusion-controlled after the 
glassy core of the hydrated tablet disappeared, as the dissolved drug was already in the 
system. 
Significantly increasing rates of poorly soluble drugs release after a complete hydration of 
the matrix core were reported. It was proposed that drug particles were reducing the 
entanglement of the polymer chains and increasing the erosion rate of the gel layer [37, 38]. 
 
There is a lot of work published concerning the impact of drug particle size in formulation 
of release rates. It was observed that release rates decreased with increasing particle size of 
insoluble drug as a result of slower dissolution of large dry particles, the surface area to 
volume ratio decreased [26, 27, 30]. 
 
On the other hand, Velasco (1999) found no dependence between the particle size of 
diclofenac Na on the release rate at low concentration of HPMC in a formulation, whilst at 
larger concentration of HPMC, as the particle size increased, the release rate increased as 
well. No reasonable explanation was given for these findings, but it is possible that the 
HPMC particle size effected the increase of dissolution rates [39].   
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1.2.1 Chemical properties of 6-hydroxy Buspirone Hydrochloride 
 
The 6-hydroxy buspirone (6OH BP) is a hydroxylated derivative of buspirone. The 
substance is produced by the hydroxylation of buspirone, which leads to the final product, 
racemic mixture of alcohols [40, 41]. Pharmaceutically acceptable acid salt can be made by 
the reaction of 6-hydroxy buspirone with organic or inorganic acid. However, the anion of 
the added acid should not contribute in a significant way to the pharmacologic or toxicity of 
the base form of 6-hydroxy buspirone. Acids commonly used for this process are 
carboxylic acids, tartaric acid, succinic acid, fumaric acid, acetic acid, HCl, HBr, HI, and 
sulfuric acid. 6-hydroxy buspirone was found in forms: racemate, R-enantiomer and S-
enantiomer. It is interesting to note that neither the racemate nor the enantiomers have been 
described in the literature properly from a chemical point of view and commercially these 
substances are not available. This project involves the use of the racemic form of 6-hydroxy 
buspirone hydrochloride BMS-528215 as an active substance in tested pharmaceutical 
formulations [42-45].   
 
 
Fig. 1-3. Chemical structure of 6-hydroxy buspirone hydrochloride 
6OH BP is a white crystalline powder, freely soluble in water, methylene chloride and 
methanol, soluble in ethanol and acetonitrile, slightly soluble in ethyl acetate, and 
practically insoluble in hexane [46].  
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Sheikhzadeh and co-workers studied the qualitative and quantitative characterization of 
buspirone hydrochloride and its polymorphs. Qualitative characterization involved 
13
C and 
1
H NMR analysis and single crystal X-ray studies. Quantitative analysis of buspirone 
hydrochloride involved usage of various techniques such as; Differential Scanning 
Calorimetry (DSC), Thermogravimetric analysis (TGA), X-ray powder diffraction (XRPD), 
laser Raman spectroscopy and FTIR. The polymorphs were distinguished on  the basis of 
their melting points, XRPD and vibrational peaks, also various chemometric methods such 
as partial least squares (PLS) and principal component regression (PCR) were used in order 
to develop calibration curves for quantitative analysis of the collected data [47, 48]. 
 
FTIR spectroscopy of solid state 6-OH BP hydrochloride (Fig.1-4) showed the presence of 
characteristic bands for buspirone hydrochloride. The spectrum showed a relatively strong 
absorbance band in the region 1650-1700 cm
-1
 associated with C=O stretching mode, C=C 
skeletal benzene ring breathing modes in the region 1500-1600 cm
-1
, presence of the bands 
associated with C-H in aromatic ring at 3000-3100 cm
-1
, as well as OH stretching vibration 
absorbance band at 3100-3500 cm
-1
 which appeared as a result of buspirone hydroxylation 
process. Also the band in the region 1130-1270 cm
-1 
associated with C-N stretch was 
reported [49, 50].  
 13 
 
Fig1-4. Spectrum of 6-hydroxy buspirone hydrochloride. 
Additionally single crystal studies and molecular modelling analysis performed on 
buspirone hydrochloride by Sheikhzadeh and co-workers [47,48] revealed that between the 
oxygen and nitrogen atoms in the structure the main source to accept the hydrogen atom 
from HCl molecule is N17, as nitrogen atom in this position presented the highest negative 
charge.  
 
 
Fig1-5. Chemical structure of buspirone hydrochloride [47]. 
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The hydrogen atom connected with N17 also showed the ability to form intermolecular and 
intramolecular hydrogen bonding with the chloride ion [47].  
The buspirone hydrochloride was found to make complexes with ion exchange polymers in 
tested controlled release formulations.  The complex was usually formed with anionic 
exchange resins or with easily dispersible, hydrophilic polymers with an average molecular 
weight of less than 500,000. First of all, the substances were admixed and the formation of 
the complex started after exposure to water either during preparation of the liquid dosage 
form or in situ (the solid dosage form comes into contact with the aqueous or 
gastrointestinal tract environment) [51]. There is no information available about the activity 
of the 6-hydroxy buspirone hydrochloride in complex formation, nor any data published 
about the stability of this substance. The kinetic studies made on the rate of decomposition 
of the solid state buspirone hydrochloride in bulk and in a tablet under the trade name 
BUSPAR, proved better stability of the drug in bulk than in the solid dosage form both in 
humid and dry conditions [52].   
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1.2.2 Pharmacological influence of 6OH BP  
 
Buspirone hydrochloride is an anxiolytic drug from azapirones approved for the treatment 
of anxiety disorders and depression by the US Food and Drug Administration. 
 It does not exert anticonvulsant or muscle effects and lacks the prominent sedative effect 
associated with more typical anxiolytics [53-56]. However, some adverse effects like 
dizziness, nausea, headache, nervousness, light headedness as well as symptoms of 
restlessness were reported. It became desirable to find a drug with more robust anxiolytic 
potency but with a lack of the adverse effects. Over the years, studies indicated that 
buspirone is extensively metabolized in the body. The 6OH BP is believed to be its major 
active metabolite circulating in human plasma. It has been found to be effective in the 
treatment of anxiety disorders and depression, has partial agonist activity at the 5-HT1A 
receptors and could be used as an effective anxiolytic agent alternative to the “parent 
compound’’[57-59]. The clinical studies performed on all three forms of 6OH BP: 
racemate, R-enantiomer and S-enantiomer did not show any advantages of one form of the 
other regarding pharmacokinetics nor the tolerability. For future clinical trials and 
development the racemate was chosen as its form is fairly easy to synthesize [43-45].    
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1.3 pH modifiers 
 
Drug release is influenced not only by the properties of polymer matrices or active 
substances but also by those of drug release modifiers. These can be soluble and insoluble 
components. It was reported that replacing HPMC (reduced to 50 %) with an insoluble 
component resulted in an increased drug dissolution rate being observed. Also the presence 
of surfactants can enhance the drug release rate by controlling wettablilty [33]. The addition 
of other polymers showed some influence for drug release (depending on active substances 
and the kind of polymer used). Hypromellose showed pH independence in the range 3-11. 
However pH changes may affect the ability of the polymer to swell. That applies to the 
external environment surrounding the tablet and gel as well as the microenvironment within 
the gel matrix. If an acidic drug is buffered to a pH above its pKa and then dissociated, the 
drug may have a better solubility which results in a faster drug-release process. 
Acidification of the matrix core stabilizes the gel pH microenvironment such that the 
particular pH is maintained within the matrix core. It should potentially stabilize the drug 
release profile of a pH dependent drug [33].  Addition of organic acids to the hydrophilic 
matrices allows the maintenance of low pH values within the tablets during drug release in 
phosphate buffer (pH 6, 8 or 7). The most common organic acids are: citric, tartaric, 
fumaric, maleic and succinic acid.  
Organic acids are used as pH-stabilizers within the core. Without organic acids, 
once the pKa value of the weakly basic drug or the pH value at which drug precipitation 
occurs is exceeded by the pH of intestinal fluids, precipitation of the weakly water-soluble 
free base takes place within the dosage form.  The precipitated drug is no longer capable of 
diffusing through the film coating and is not released. By adding organic acids, the pH 
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value within the core is maintained and a constant drug release can be achieved over the 
wide pH range (depending on the type and amount of organic acids)  
Depending on strength of the organic acid we can observe different dissolution rates 
followed by controlled release of the tablet. The strength of an acid in water i.e. the extent 
to which it is dissociated, may be determined by the equilibrium [30]: 
 
                    HA + H2O -> H3O
+
 + A
–
           (eq1.2) 
 
Then the equilibrium constant in water is given by: 
             
                                           (eq1.3) 
 
Ka is a specific type of equilibrium constant that indicates the extent of dissociation of 
hydrogen ions from an acid. The equilibrium is that of a proton transfer from an acid, HA, 
to water, H2O. 
Because this constant differs for each acid and varies over many degrees of magnitude, the 
acidity constant is often represented by the additive inverse of its common logarithm, 
represented by the symbol pKa (using the same mathematical relationship as [H
+
] is to pH). 
 
pKa = −log10 Ka                                                 (e.q1.4) 
 
In general, a larger value of Ka (or a smaller value of pKa) indicates a stronger acid, since 
the extent of dissociation is larger at the same concentration. 
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The acid dissociation constant Ka is determined by the difference in free energies ΔG° 
between the reactants and products, specifically, between the associated (AH) and 
dissociated (A
–
) states. Molecular interactions that favour the dissociated (A
–
) state over the 
associated (AH) state will increase Ka (because the ratio [A
–
]/[AH] increases) or, 
equivalently, decrease pKa. Conversely, molecular interactions that favour the associated 
(AH) state over the dissociated (A
–
) state will decrease Ka (because the ratio [A
–
]/[AH] is 
lower) or, equivalently, increase pKa. 
The magnitude of the pKa shift can even be determined from the change in ΔG° using the 
equation  
 
                                            (eq1.5) 
 
 
Fig1-6 Structure of citric acid 
 
The pKa value(s) of a compound influence many characteristics of the compound such as 
its reactivity, solubility and spectral properties (colour). Very weak acids ( with pKa  greater 
than 16 ) will not deprotonate in water at all, but if acids are sufficiently strong ( low 
enough pKa ) they will be essentially fully ionised in water and will thus all appear to be of 
the same strength - which is known as the levelling effect of water.  
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Fumaric and citric acid have similar values of pKa and they are stronger acids than succinic 
acid. As a consequence these two former acids when in a water environment would  
dissolve faster than the succinic acid, and so in a HPMC matrix tablet the addition of 
fumaric or citric acid will allow the active substance to diffuse out from the tablet quicker. 
Addition of citric acid to the HPMC matrices produces greater dissolution rates 
(depending on the amount). This effect is considered to be mainly due to a loosening of the 
matrix after dissolution and release of its citric acid content
.
 The effect of adding an acid is 
especially marked if the acid is in the tablet matrix. The effect is weaker if the acid is in 
granule cores. Formulations can be optimized by adding varying amounts of acid. 
The advantage of using organic acids during formulations is that the local pH of the 
environment of our tablet can be controlled, which is very important because it can change 
the speed of drug release [60-62]. 
 
The infrared spectrum of citric acid (Fig 1-7) showed in the region ~3570-3200 cm
-1
 ν(OH) 
the bands associated with the presence of hydroxyl groups from the chemical structure of 
the acid. 
 
Fig1-7 The infrared spectrum of pure citric acid.  
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In the region ~3570-3200 cm
-1
 ν(OH) the band is  associated with the presence of hydroxyl 
group in the chemical structure of the citric acid. The shape of it is modified by the 
presence of ν(OH)  band associated with citric acid where non hydrogen bonded hydroxyl 
group forms narrow sub-maximum peak ~3500 cm
-1
 as well as OH bonded stretching 
absorption at lower wavenumber within the discussed region. The secondary absorption for 
ν(OH) near the ~2600 cm-1 region is observed as the effect of overlap of the CH stretching 
region. The citric acid bands are also observed at ~1750-1680 cm
-1
 region associated with 
the characteristic carbonyl group C=O stretching frequency, and with presence of ~1175-
1045 cm
-1
 strong absorption ν(CO) and ~955-890 cm-1 region associated with OH 
deformation vibration of carboxyl group [31, 32].  
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1.4 Drug release from hydrophilic matrices 
 
Matrices containing HPMC prolong drug release by rapidly forming a protective layer 
around the tablet surface when exposed to aqueous liquids. This hydrated viscous layer 
controls water penetration into the central dry core of the tablet and prevents disintegration. 
During the exposure of the polymer to an aqueous medium, HPMC undergoes rapid 
hydration and chain relaxation to form a viscous layer which is commonly termed the “gel 
layer”, at the surface of the tablet [37, 39].  If the uniform gel layer is not formed it may 
cause immediate drug release as the gel layer controls water uptake and modifies the 
mechanism of drug release from the matrix. The gel layer growth is observed as water 
permeates through it to hydrate the polymer particles. In the same time outer layers become 
fully hydrated and dissolve.  
 
Water continues to penetrate towards the core of the tablet until the tablet has fully 
dissolved. Considering that during water uptake and drug release, the gel layer will contain 
polymer, drug and excipients experiencing different degrees of hydration or solution, it is 
generally assumed that water soluble drugs are released primarily through diffusion through 
the gel layer (Fig 1-8) and that poorly water soluble drugs are primarily released through 
erosion process [26, 27].  
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Fig.1-8 Schematic representation of the formation of the gel layer upon hydration of HPMC 
matrix tablet and the mechanism by which drugs are released. 
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Drug release at the molecular level is determined by polymer swelling, polymer front 
movement, drug dissolution, diffusion and matrix erosion. During the hydration of the 
HPMC one could select stages: liquid penetration, uncoiled and extended chains of the 
polymer and broken polymer hydrogen bonds which makes sites for hydrogen bonding 
with water molecules and leads to polymer mass entanglement with increasing content of 
water layer formation of gel layer by retardation of water uptake by the rest of tablet 
ingredients. 
When the gel layer is formed the rate of drugs release is often reduced and dependent on 
the rate which: the drug molecules diffuse through the gel and the barrier layer is 
mechanically removed by attrition and disentanglement. Diffusion and erosion in most 
cases can occur simultaneously. 
 
Colombo [66] suggested identification of three different distinct moving fronts (Fig. 1-9):   
- swelling front: boundary between still glassy polymer (water has yet to fully penetrate the 
matrix) and its rubbery state (gel layer), the mobility of macromolecules is very low which 
leads to low diffusion rates of drug  
- erosion front: boundary between the matrix and dissolution medium, mobility of polymer 
chains is increased – higher rates of active substance diffusion process 
- diffusion front: boundary in the gel layer itself between solid and dissolved drug – here 
occurs drug dissolution. 
The thickness of the dissolved drug-gel layer is the main controller for drug release. 
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Fig 1-9 Schematic illustration of a swell able hypromellose-based matrix during drug 
release [33]. 
 
Movement of the erosion front determines drug release kinetics.  
In the case if the polymer in the diffusion front is diluted so that the gel has no structural 
integrity it dissolves and erodes [33, 36]  
Siepmann (Fig. 1-10) suggested that as the polymer concentration in the gel layer decreases 
towards the outer edge of the gel layer the polymer molecules entangle and disentangle 
without restriction. As the concentration decreases the rate of disentanglement exceeds re-
entanglement and the gel layer erodes. The outer region of the gel layer represents polymer 
hydrated to the point where it no longer has structural integrity and may dissolve or erode  
away [63]. 
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Fig. 1- 10 Process involved in polymer dissolution, (A) non-swollen polymer, (B) swelling 
polymer with water concentration gradient, (C) disentangling polymer molecules (D) 
unstirred layer with the polymer –concentration gradient [14].  
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1.5 Drug release kinetics 
 
Drug release in general is not purely swelling controlled, since it occurs mostly as the result 
of a combination of polymer relaxation and Fickian diffusion. The equation was proposed 
to describe drug release kinetics from drug delivery systems controlled by swelling [64]. 
The equation is based on power law dependence 
 
nt kt
M
M


                                                 (eq.1.6) 
 
Where 
 Mt is the amount of drug released at time t,  
M∞ the amount of drug released at infinite time,  
k a kinetic constant 
n is the diffusional exponent.  
 
Based on the value of the diffusional exponent the drug transport in slab geometry is 
classified either as Fickian diffusion (n = 0.5), non-Fickian or anomalous transport  
(0.5 < n < 1), or Case II transport (n = 1), where the dominant mechanism for drug transport 
is due to polymer relaxation during gel swelling. Anomalous transport occurs due to a 
coupling of Fickian diffusion and polymer relaxation.  
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The mechanism of drug release from HPMC matrices depends on many parameters 
including drug solubility, geometry of the dosage form and the conditions under which the 
drug is released. Siepman et al [64] proposed that the overall mechanism of drug release  
is subject to many influences 
 
1) An initial steep water concentration gradient at the matrix surface leading to 
inhibition of water into the matrix. The process is affected by the geometry of the 
system and in the case of cylindrical tablets the mass transport of water in axial and 
radial direction should be considered 
2) Swelling of HPMC leading to changes in polymer and drug concentrations and 
increasing the dimensions of the tablet 
3) Dissolution and diffusion of the drug in the hydrated medium out of the matrix as a 
result of the concentration gradient 
4) Changes in the diffusion of the drug in the hydrated medium out of the matrix as a 
result of concentration gradient 
5) The drug type as poorly soluble drugs may exist in the gel as either dissolved drug 
able to diffuse out of the matrix and non-dissolved drug particles released by the 
erosion 
6) Drug loading as for high drug loadings the gel layer structure may change 
significantly during release resulting in more porous and erodible gel layer as drug 
is released 
7) The type and molecular weight of HPMC used and its associated dissolution rate 
[13, 63, 64]. 
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Higuchi [65, 66] derived the equation designed to predict the release of medicaments from 
ointments and creams  
                                                          tk
M
M t 

                                                       (eq1.7) 
Where  
K and t is a constant related to the geometry of the system  
Mt/Mω is the fraction of drug released at time t 
 
This equation is the most often used to describe the release rate of drugs from matrix 
system as a result of simplicity.  
 
The Higuchi model assumes: 
 
1) The suspended particles are smaller in diameter than the thickness of the system 
2) The initial drug concentration in the matrix exceeds the solubility of the drug 
3) Mathematical analysis of diffusion is one-dimensional and as a result the effects of 
water penetration in axial and radial directions at the edge of tablets are considered 
negligible 
4) Swelling or dissolution of HPMC is considered negligible and therefore the drug 
release occurs mainly by diffusion 
5) Diffusivity of the drug is constant 
6)   Perfect sink conditions (conditions referring to the excess solubilizing capacity of        
the dissolution medium assuring the complete dissolution of the drug) should be maintained 
[65, 66]. 
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There is no universal drug release mechanism valid for all HPMC based systems. 
Different mathematical models may be applied for describing the kinetics of the  
drug-release process from matrix tablets, the most suited being the one which best fits 
the experimental results. 
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1.6 Aims of the thesis: 
 
 To optimize the preparation process of proposed pharmaceutical formulations 
ensuring the content uniformity of the mixtures  
 To manufacture the reproducible tablets in-situ on the ATR crystal and build a PLS 
model to predict the concentration values for the particular excipients of analyzed 
formulation 
 To confirm the distribution of the components in the tablets using imaging 
techniques.   
 To investigate the drug release from binary and tertiary formulation in different 
media  
 To conduct the analysis of interactions of the components in an aqueous 
environment     
 To monitor the hydration and hyphenation experiments (by coupling the FTIR, UV 
spectrophotometer and HPLC pump) and develop information about the formulation 
behaviour in static and dynamic conditions 
 To validate MCR as a tool to study such systems and conduct the analysis of the 
analyzed systems  
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2. Materials, methods and techniques 
 
 
2.1 Materials 
The materials used to make the model pharmaceutical formulations involved the 
amphiphilic polymer HPMC as the controlled release matrix tablet, citric acid to potentially 
modify microenvironmental pH, and the active substance. Further information about 
investigated formulation excipients are available in Chapter 1 (Section 1.1, 1.2, 1.3). 
Materials used in the project 
Substance Structure of the substance Material no. Batch no. 
Hydroxypropyl 
methylcellulose 
HPMC USP H VISC 
 
 1020278 4K83846 
Citric acid anhydrous 
FCC USP 
 
1020402 4D84505 
BMS 528215-02 
6-0H Buspirone 
HCL salt 
 
1136941 4K85703 
Table 2-1 The substances used for the project. 
Hydroxypropyl methylcellulose (HPMC type 2208) grade K4M, 6-hydroxy buspirone 
hydrochloride and citric acid were a gift from Bristol-Myers Squibb and used as received 
without further purification. 
Compounds used for dissolution testing and hyphenation experiments: 
Hydrochloric acid, ACS reagent 37%, sodium hydroxide, solid, potassium dihydrogen 
orthophosphate were obtained from Sigma- Aldrich Co. Ltd Dorset UK 
 
n 
ROH2C
6
OR      ROH2C
RO
O
OR
RO
O
O
3
4
2
1
5
O
1
O
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2.2 Methods and techniques 
2.2.1 Infrared Spectroscopy 
 
      Infrared spectroscopy has been widely used for materials analysis in the laboratory for 
over seventy years. This useful technique can be used to provide qualitative and 
quantitative information of investigated materials. An infrared spectrum represents a 
fingerprint of a sample with absorption peaks which correspond to the frequencies of 
vibrations between the covalent bonds of the atoms making up the material. 
Infrared radiation is electromagnetic radiation combining all the wavelengths between the 
visible and microwave region of the electromagnetic spectrum.  
The IR region can be divided into three main sub regions: near IR ranging from 13,000 to 
4,000 cm
-1
, mid IR ranging from 4000 to 400 cm
-1
 and far IR ranging from 400 to 10 cm
-1
   
IR spectroscopy is a rapid method, which can be useful in kinetic studies of dynamic 
experiments. 
        
2.2.1.1 Principles of infrared spectroscopy 
 
In molecules, bonds vibrate in a variety of ways, and the vibrational energies of molecules 
may be assigned to quantum levels in the same manner as their electronic states.  
A molecule consisting of two atoms is supposed to keep the balance between the attractive 
and repulsive forces and maintain the energy of the system at minimum. However all 
attempts to squeeze or pull apart the atoms would require an input of energy as the 
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repulsive/attractive forces will rise rapidly. The bond would likely behave like a spring and 
follow Hooke’s law: 
                                                          eqrrkf                                                   (eq. 2.1) 
f – restoring force,  
k - force constant 
r - intermolecular distance 
req- intermolecular distance at equilibrium 
 
The potential energy curve of such a system is parabolic and is given by: 
   2
2
1
eqrrkE                                                   (eq.2.2) 
k- force constant of the bond 
A diatomic vibrating molecule system, as described above, is known as the simple 
harmonic oscillator model (SHO). As the vibrational energies are quantized, it is possible to 
calculate the allowed vibrational energies using the Schrodinger equation: 
                                                 oscv hvE 






2
1
       (ν = 0,1,2,3,…)                       (eq.2.3) 
ν- vibrational quantum number 
h- Planck’s constant 
ωosc – oscillating frequency 
Further use of the Schrodinger equation will lead to the simple selection rule for 
undergoing vibrational changes in harmonic oscillator where 
                                                        1v                                                                  (eq.2.4) 
Real molecules however don’t harmonically oscillate therefore the bonds don’t obey 
Hooke’s law. Although the bonds are elastic, larger amplitudes of vibration can lead to 
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bonds breaking, which lead to the dissociation of the atoms. The Morse function is an 
empirical approximation for the potential energy in a real diatomic system and is given in 
the eq 2.5: 
                                                    2}exp{1 rraDE eq                                            (eq.2.5)                   
D – depth of the potential minimum 
a – constant 
The dissociation energy of the molecule can be found by substituting energy levels from 
Morse function into the Schrodinger equation and has a form: 
                                          

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










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
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2
1
2
1
1 vvxeev                                     (eq.2.6) 
 xe - anharmonicity constant 
 
Figure 2-1. Energy diagram of the anharmonic diatomic oscillator [67] 
The general observed transitions are: v = 1←0 represents fundamental, v = 2←0 represents 
1
st
 overtone, v=3←0 2nd represents overtone. The energy at v=0 is termed as zero point 
energy however the real amount can be calculated from equation 2.6 
Although most molecules are examples of polyatomic systems, the theory from diatomic 
molecules is useful to understand their spectra after modification [68].  
 35 
A polyatomic molecule with n atoms has 3n degrees of freedom which corresponds x; y 
and z coordinate axes. To describe translational motion and rotational motion of the 
molecule additional 3 degrees are required. For nonlinear molecules 3n-6 degrees of motion 
are true fundamental vibrations, for linear ones 3n-5 degrees of freedom.  
Usually polar bonds yield strong IR absorption. Modes which produce a change in the net 
dipole moment of the molecule are determined IR active while those which produce a net 
polarisability change are Raman active. The resultant band in IR spectroscopy is a 
fundamental vibrational band with intensity proportional to the square of the change in 
dipole moment. If the band arises from the combination of two or more different 
frequencies it's called a combination band. Also particular frequencies may give multiple 
bands belonging to a single band and they are referred to overtones. The frequency of the 
overtone is an integer multiple of the fundamental frequency, although the intensity is much 
lower.  
The intensity of the band in an infrared spectrum can be modified by the amount of sample 
in the beam, vibrational level population and selection rules, for example, symmetry. 
The Boltzmann distribution can be used to calculate the initial vibrational state at thermal 
equilibrium, which has an impact on the intensity of the spectral line. At room temperature 
the ground state is the most populated. [68-73] 
Quantitative measurement of concentration can be obtained from infrared spectroscopy 
using the Beer-Lambert law:  
                                           )exp( clII o                                                                  (eq.2.7) 
or in the logarithmic form  
                                           log
I
I
cl
0




                                                                      (eq.2.8) 
Where: 
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I- transmitted intensity 
Io= incident radiation 
l - path length   
ε = frequency dependent extinction coefficient 
c – concentration 
 
2.2.1.2 Instrumentation 
 
           IR radiation can be measured by a dispersive spectrometer (in high-precision work) 
but more commonly using Fourier Transform Infrared spectroscopy (FTIR). Fourier 
transform involves the conversion of the time domain instrument response into the 
frequency domain spectrum. Modern FTIR instruments are based upon the Michelson 
interferometer, which is an optical device that splits a beam of radiation into two paths and 
recombines them; the intensity of variations of the exit beam can be measured by a detector 
as a function of path difference. The interferometer consists of four arms (Fig. 2-2). The 
first arm contains a source of infrared light (A) such as a mercury lamp or a silicon 
(Globar) rod, the second and third arm contain two mutually perpendicular planed mirrors - 
fixed mirror (C) and movable mirror (D) and the fourth arm is open.  The movable mirror is 
moved at a constant velocity over the fixed distance and is also responsible for the quality 
of interferogram. A parallel, polychromatic beam of radiation from source is directed to the 
beamsplitter (B), a piece of semi-reflective material, such as thin Ge coating sandwiched 
between two pieces of KBr, where a beam of radiation from the source is split with 
approximately half of the light going to the fixed mirror which reflects the light back to the 
beamsplitter. KBr acts as a transmitter of radiation, and protects the beamsplitter coating 
from the environment. The rest of the light passes through to the moving mirror; and this 
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beam is also reflected back to the beamsplitter. The combined portion of the light which has 
travelled to both mirrors reaches the sample (E) and is transmitted towards to the detector 
(F) and the result is an interferogram. The major detectors used in mid-infrared systems are 
deuterated triglycine sulfate (DTGS) or liquid nitrogen cooled mercury cadmium telluride 
(HgCdTe), the so called “MCT” detector [67, 74, 75].    
 
Fig. 2-2. Scheme of a FTIR instrument. 
 
Depending on the path distance the light would travel between mirrors and beamsplitter, 
there will be constructive (radiation in phase) and destructive (light beams out of phase) 
interference present. As the moving mirror changes the position against the beamsplitter, 
depending on the rate the distance the mirror moves and frequency of the light beam, 
different wavelengths of the radiation will be in phase and out of phase at the frequency. 
The pattern of overlaying sinusoidal waves which is in the time domain is defined as an 
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interferogram. The interferogram is converted by means of Fourier transform and the result 
is a spectrum [75-78].     
 
2.2.1.3 Advantages and limitations of FTIR spectroscopy 
 
There are various advantages of the FTIR technique over conventional dispersive 
spectrometers. A few of the advantages of FTIR spectroscopy approach are outlined below. 
 
1) The throughput (Jaquinot) advantage:  
In FTIR instruments there are no slits restricting the wavenumber range and therefore no 
reduction of the radiation intensity unlike the traditional dispersive approach. This results in 
increased light energy passing through the sample, thus improving the signal to noise ratio 
when compared to the dispersive systems. 
The spectral optical conductance of a dispersive instrument is given by: 
                                            G
hH
f
RG 
 0                                                                      (eq.2.9)  
Where GG  is the optical conductance per wavenumber of grating,  
            H is the height of the grating, 
            h is the length of the entrance slit, 
            f is the focal length of the collimator, 
            R0 is the theoretical resolving power. 
The interferometer optical conductance is expressed by:  
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                                              G
H



1
22
                                                                   (eq.2.10) 
The ratio of these two optical conductances (eq.2.11) equates to throughput around 100 
times more in an FTIR system than in dispersive instrument. 
                                                
G
G
f
hG


1 2
                                                                   (eq.2.11) 
π – constant 
f – focal length of the collimator 
2) The multiplex (Fellgett) advantage:  
The FTIR instrument can detect all the frequencies at the same time whilst the dispersive 
systems are able to measure only a small wavenumber range at a time. If the spectrum is 
considered to be made up by M individual measurements at equal frequency and resolution 
then with increasing amount of spectral details the increase of M would be observed. In the 
case of a dispersive instrument, increasing the number of spectral elements will result in an 
increase in the length of time (τ) needed to conduct a particular experiment. The signal to 
noise ratio is influenced by this advantage and for the dispersive system is given by: 
                                                            S N
M
D/ 

1
2
1
2
                                                (eq.2.12) 
For FTIR spectrometers the signal to noise ratio is proportional to the square root of the 
total number of measurements (eq.2.13) 
                                                             S N FT/ 
1
2                                                  (eq.2.13) 
The complete spectrum can be acquired much faster by FTIR spectrometers it allows an 
increasing signal to noise ratio to be achieved on the order of √M.   
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3) The Connes advantage:  
In FTIR systems, the spectral wavelength is determined very accurately by sampling at 
known time intervals given by the output of highly monochromatic laser (usually at 
wavelength of 632.8 nm). As the time intervals of measurement are accurately known, the 
process of conversing time domain spectrum to the frequency domain spectrum is also 
highly accurate. This advantage provides the analyst an absolute control of the spectral 
wavelength and enables the application of manipulative techniques like spectral 
subtraction. Signal to noise ratio can also be further improved during the analysis of the 
many collected and averaged spectra. Such a high level of accuracy means as well that 
spectral calibration is not necessary.  
   
There are some limitations with FTIR spectrometers connected with the technique itself. 
First of all the FTIR instrument doesn’t produce a spectrum, but an interferogram which is 
difficult for people to deduce information about the analyzed sample. The computational 
power (cheap and fast CPUs) to perform a Fourier transform is required; the frequency 
domain spectrum can be produced in a short time.  Another problem is that if light from the 
source is “noisy” (the Fellgett disadvantage) at a certain frequency range the detector still 
detects noise at all frequencies. Next important issue for the analyst from the practical point 
of view is presence of the CO2 and water vapour bands in the spectrum. These unwanted 
bands can be eliminated by purging the sample compartment with infrared inactive dry gas 
like nitrogen during the measurement or subtraction process. Another disadvantage which 
is the cost of FTIR instrument becomes less important nowadays in comparison with 
similar price of single frequency dispersive system [75].   
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2.2.1.4 Sampling techniques 
 
Infrared spectroscopy gives a choice of sampling technique depending on the specific type 
of samples one would like to study. Each approach has its own strengths and weaknesses. 
This section will discuss only the sampling techniques relevant to the project.  
 
2.2.1.4.1 Transmission  
 
Transmission (Fig. 2-3) is the most basic technique where infrared irradiation is passed 
through the sample and the transmitted radiation is measured. The spectrum obtained 
represents the whole sampled area i.e. the bulk sample. This method is useful for thin 
samples (<10 μm), or during the investigation of weak bands like overtones in thicker 
samples [79]. Solid samples may require preparation before the measurement for example 
preparing KBr pellets or dispersions in Nujol mull, which is a time consuming process and 
difficult to reproduce. 
 
 
 
   Fig. 2-3. The transmission experiment. 
The transmittance is given by: 
0I I
source 
detector 
sample 
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                                                T
I
I
  
0
exp l                                                       (eq.2.14) 
I – transmitted intensity 
I0 – incident intensity 
α – molar extinction coefficient 
l - sample thickness 
 
2.2.1.3.2. Attenuated total reflectance spectroscopy (ATR) 
 
Attenuated total reflectance is also known as internal reflectance spectroscopy and is where 
the sample is placed in contact with an internal reflection element (IRE) of higher refractive 
index (Fig. 2-4). The technique is used to obtain spectra of thick solids, strongly absorbing 
liquids, semisolids, thin films, fibres, pastes and samples difficult to analyze using 
transmission (Fig. 2-3) as a sampling method [79, 80]. 
 
 
 
Fig.2-4 Schematic of ATR experiment 
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The presence of the evanescent field created at the surface of the ATR crystal is one of the 
most important theoretical aspects of ATR spectroscopy. Infrared light passes through the 
optical denser, medium with high refractive index (ATR crystal) at an angle of incidence 
greater than the critical angle (θc) and reflects at the interface of rarer medium, the material 
with lower refractive index (sample). The propagating light passes through the ATR crystal 
but an electric field penetrates into the sample and the intensity of the electric field decays 
exponentially with increasing distance from the interface. This non-transverse wave is 
known as an evanescent field and its rate of decay depends on angle of incidence and 
wavelength of the light, as well as on the refractive indices of the denser and rare media.  
If the sample absorbs radiation, the reflection is said to be attenuated; in the case of a none 
absorbing medium the reflected rays will show the same intensity as the incident ones.  
Total internal reflection occurs when the incident angle is greater then the critical angle. 
During the reflection there should be no radiation lost in an ideal system unless it is 
absorbed by propagating medium, practically the ATR material should have a high 
refractive index and be infrared transparent. Commonly used materials for ATR crystals are 
shown in a Table 2-2. 
 
Material Refractive index Spectral range (cm
-1
) 
ZnSe 2.4 20,000 - 650 
KRS-5 (TII2/TIBr2) 2.4 20,000 - 350 
Ge 4.0   5,500 - 870 
Si 3.4 8,300 - 1100 
           Table 2-2. Common materials used for ATR crystal and some their properties. 
The most important properties of the evanescent field are as follow: 
1) There is no loss of energy between the rarer and denser media and propagating 
radiation in the ATR crystal is totally internally reflected. 
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2) The evanescent field is confined to the surface of the sample and deceases in 
intensity with the distance to the interface along z-axis. 
3) The evanescent field is a non-transverse wave which has components in all spatial 
directions.  
4) There is non-zero energy flow along the x-axis, parallel to the surface which  results 
in a so called Goos-Hanchen shift; displacement of the incident and reflected waves. 
 The decrease in intensity of the evanescent field at the surface of the rarer medium is 
expressed by: 
                                  E E n z  0
1
2
21
2
1
2
2
exp sin


                                              (eq.2.15) 
Where E is the value of the electric field at distance Z into the sample 
            E0 is the electric field amplitude at the surface of the sample 
            θ is angle of incidence 
             λ1 is wavelength of the radiation in the ATR crystal ( λ1= λ/n1) 
Exponential constant is replaced by the electric field amplitude decay coefficient γ giving:             
                                                     E E Z 0 exp                                                      (eq.2.16) 
                                              
 

 


2 2
21
2
1
2
1
sin n
                                               (eq.2.17) 
In the rarer medium the depth of penetration (dp) of the evanescent field is defined as the 
depth (Z) at which the value E equals to E0 exp[-1] 
                                                     Z d p 
1

                                                           (eq.2.18) 
However the real sampling depth of penetration (de) is approximately three times dp. The 
thickness of the sample which gives the same absorbance for the transmission experiment 
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at normal incidence is known as effective thickness (de). The dependence between 
reflectivity and the effective thickness in the realistic case of rarer medium is given by: 
                                                R
I
I
d a
R
e    
0
1exp                                        (eq.2.19) 
                                                             a de                                                            (eq.2.20) 
Where R is reflectivity 
            a is the absorption parameter for single reflection 
            α is absorption coefficient the same as for transmission 
If one would like to calculate the effective thickness (de) the electric field components 
needs to be determined. 
Electromagnetic wave has two polarizations; the transverse magnetic (TM) which is 
parallel to the plane of incidence and the transverse electric (TE) perpendicular to the plane 
of incidence. The TM has components in the x and z planes whilst the TE wave have 
components in the y plane.                                                         
                                                          TE E Ey                                                    (eq.2.21) 
                                                    TM E E Ex z  ||
2 2
                                     (eq.2.22) 
The properties of the evanescent field depend on thickness of the rarer medium. Two cases 
can be determined; the semi-infinite bulk where the electric field amplitude falls to the very 
low value within the thickness of the sample (t >> 1/γ) and the thin film case where the 
electric field amplitude value remains constant over the thickness of the film (t << 1/γ). 
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The semi-infinitive bulk case: 
 TE wave, 
                                                          
 
E
n
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2
1 21
2
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                                                (eq.2.23) 
TM wave, 
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n
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2
1
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The thin film case: 
TE wave, 
                                                           
 
E
n
y 

2
1 31
2
cos
                                               (eq.2.26) 
TM wave, 
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Plotted values of electric field amplitudes for different angles of incidence (Fig 2-5) 
showed that Ey and Ez reach maxima at the critical angle, Ex is equal zero. At the point 90
o
 
the electric field amplitude is zero for all directions. 
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Fig. 2-5. The variations of calculated electric field amplitudes with angle of incidence for 
polarized radiation. 
The relation between the electric field E and the absorption parameter a, is given by: 
The thin film case: 
                                                    a
n
E dZ
t
 
21 2
0

cos
                                                   (eq.2.29) 
The semi-infinite bulk case: 
                                                 a
A
N
n C
E dZ 


21 2
0

cos
                                           (eq.2.30) 
Where A is absorbance 
           C is the concentration 
           N is the number of reflections 
           α is the molar absorption coefficient 
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Giving: 
                                                        a
n E

21 0
2
2

 cos
                                                       (eq.2.31) 
And for the thin film case where (t =d): 
                                                        a
n dE

21 0
2
cos
                                                      (eq.2.32) 
Where d is a film thickness 
By the substitution of the equations 2.32 into 2.21 for thin film case and 2.17 and 2.23-2.25 
for semi-infinitive bulk case one gets 
The semi-infinitive bulk case 
TE wave, 
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TM wave. 
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The thin film case 
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The total effective thickness is given by: 
                                                        d
d d
e
e e
u

 ||
2
                                                (eq.2.37) 
The effective sampling thickness (deu) depends on parameters like the electric field decay 
constant (γ), the wavelength of radiation (λ), the angle of incidence (θ), the electric field at 
the surface (E0
2
), the sampling area and refractive indices of rarer and dense medium [79-
83].  
The analyzed samples have different refractive indexes based on the type of formulation 
and whether the sample is a solid dosage or hydrated form. Considering the dependence of 
depth penetration and wavelength of the incoming radiation; the depth of penetration will 
be greater at higher wavelengths using the FTIR-ATR technique whilst the NIR shows the 
reverse phenomena the longer the wavelengths the less penetration into the sample.   
The ability to control the sampling depth has allowed for concentration-depth profiling of  
absorbing species, however in order to achieve good quality, reproducible data, pressure 
needs to be applied to the sample to ensure good contact between the sample and ATR 
crystal. 
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2.2.2 NIR Imaging 
 
NIR chemical imaging (NIR-CI) is a rapidly emerging analytical methodology that 
combines the strengths of both digital imaging and near infrared (NIR) spectroscopy. The 
technique provides qualitative and quantitative insight into chemically heterogeneous 
samples in the form of high resolution chemical maps showing the visual location of 
components within the analyzed samples [34].  
In this project, the NIR Chemical Imaging approach was used to determine the distribution 
of components in the investigated tablets, which will have a significant impact on release 
properties of the formulation.  
 
2.2.2.1 Fundamentals of NIR-CI 
 
Hyperspectral or Chemical Imaging is a technique which allows spatially resolved 
collection of sample spectra. The spectra are obtained at each data point in the spatial 
image. Spectral images are visualized as a three-dimensional block and termed a hypercube 
(Fig. 2-6). One of the three dimensions is wavelength (λ) and the other two are the spatial 
dimensions (x and y).  
The hypercube can be visualized as channels or pixels. Pixel is spatially resolved spectrum 
so called as one detector element. Selections of the particular pixels will yield spectra at the 
particular spatial point. Channels or the Image planes are spectrally resolved images, which 
yield the spatial image information at a particular wavelength point [84]. 
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Fig.2-6 Scheme of spectral imaging hypercube representing the spectral and spatial 
dimensions [85]. 
The 3-dimensional cube shown in Figure 2-6 consists of both spatially resolved spectra and 
wavelength-dependent images. The X and Y axes represent spatial information, and the λ 
axis represents reflectance at the selected NIR wavelengths. The image cube can be seen as 
a series of wavelength-resolved images (i.e. the image plane in Fig. 2-6C) or as a series of 
spatially resolved spectra (i.e. the spectra in Fig. 2-6B), one for each point on the pixel. The 
complete integration of spatial and spectral information adds a new dimension to data 
analysis. The ability to explore the interdependency of spectral and spatial information is 
the basis for its unique capabilities which is different qualitatively from simple point-by-
point spectroscopy [85, 86]. 
NIR Chemical Imaging also combines the benefits of NIR spectroscopic measurements. 
The near infrared region of the electromagnetic spectrum extends along the range 780–2526 
nm (12800 – 4000 cm-1). The technique is based on molecular overtone and combination 
bands from stretching and bending vibrations, of predominantly O-H, C-H and N-H 
B 
A 
C 
one channel 
one pixel 
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functional groups, since the absorption bands in the near infrared region are typically quite 
weak, NIR can be used to analyze much thicker samples due to the size of the wavelength, 
it penetrates much further into a sample than mid infrared radiation [84, 87, 88]. Near 
infrared spectroscopy is therefore not a particularly sensitive technique, but it can be very 
useful in probing bulk material with little or no sample preparation. The molecular overtone 
and combination bands seen in NIR spectrum are typically very broad, often overlapping, 
leading to complex spectra; one can find it difficult to assign specific features to specific 
chemical components. Careful development of a set of calibration samples and application 
of multivariate calibration techniques is helpful for near infrared analytical methods [89].  
2.2.2.2 Instrumentation 
Chemical Imaging (general specification) radiation sources are usually quartz-tungsten 
halogen lamps with adapters for polarization and filtering connected to an integral 
computer system to control sample illumination. The sample is placed on a precise XYZ 
stage which can be operated manually or programmed for automated measurements of 
multiple samples (Fig 2-7). Typical scan times of the sample area are ~2 minutes, after the 
background and dark-field images are measured. The radiation interacts with the surface of 
the sample and it is diffusely reflected to the imaging optics. The camera allows the 
flexibility of directing it at fields of different areas, by the use of interchangeable refractive 
objectives. The refractive objective lenses are able to provide sample magnification. The 
Field of View (FOV) 12x10 mm (FOV’s of 3x2.5 mm to 25x20 mm are available with 
optional objectives) and resolution 9 µm/pixel at 2x2 mm; 39.7 µm/pixel at 12x10 mm; 50 
µm/pixel at 13x10 cm. The diffuse reflectance image of the sample passes through the 
liquid crystal tunable filter LCTF. The tunable filter uses electrically controlled liquid 
crystal elements to select a specific wavelength of light for transmission through the filter at 
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the exclusion of all others. The LCTF in this NIR Chemical Imaging system covers a 
spectral range of 1200-2450 nm.  
 
 
 
 
 
 
 
Fig 2-7. Schematic diagram of the NIR Chemical Imaging system used in this study. 
 
A series of images of the investigated sample are captured by the NIR sensitive Stirling-
cooled InSb Focal Plane Array (FPA) detector. The array contains 320x256 pixels or  
81,920 equivalent spectra. The camera can be directed at different fields of view varying 
the sampling area by the interchangeable refractive objectives.   The vibrational spectra 
collected for each pixel on the array detector creates a third dimension, the obtained data 
sets are referred to as the hyperspectral image cubes or hypercube [86, 87, 90, 91].  
The system is supplied with a versatile chemical imaging analysis software package, ISys. 
ISys provides all the usual multivariate routines available in a NIR spectral software 
package and is compliant to 21 Code of Federal Regulations (CFR) part 11 [92, 93].   
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2.2.2.3 Data processing 
In order to generate the chemical maps of the excipients distribution, the appropriate data 
analysis following the selection of the wavelength and spectral pre-processing is required. 
Data pre-processing removes the interfering parameters such as light scattering and 
possible path length variations caused by the physical properties of the sample. The pre-
treatment methods include: 
1) Mean centring: this calculates the average spectrum from all the spectra in a data 
set. The calculated value is subtracted from each vector (spectrum) in the data set. 
Also the mean concentration value of constituents (components) present in the 
analysed sample is calculated and subtracted from the individual excipient 
concentration. Mean centring removes the common variations (intensity of the 
peaks, etc.) from the data and is applied before calculating any model from the 
analysed data set [94]. 
2) First and second derivative: this corrects the baseline effects in spectra removing 
variations in baseline offset and baseline slopes. The first derivative measures the 
slope of the spectral curve at each point and removes any baseline offset. The 
second derivative measures the changes in the slope of the analysed curve and 
removes baseline offset and slope from a spectrum. It also takes away the offset of 
the first derivative.   
3) Smoothing and filtering: this improves the signal-to-noise ratio of the recorded 
signal. The most commonly applied type is Savitzky-Golay polynomial smoothing. 
The polynomial smoothing function is fitted by least squares to the data using a 
specified number of data points before and after the derivative point. The Savitzky-
Golay method gives control over the smoothing parameters during derivative 
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processing and avoids derivative noise enhancement which can appear while 
removing offsets [95-97].  
4) Normalization: this corrects the spectra for indefinite path length or isolates the 
band of the constant concentration component. The spectra are normalised taking 
into consideration the area under the curve of the entire spectrum. It is important to 
avoid the interference of offsets and concentration variations between analysed 
samples and standards. 
5) Standard Normal Variate transform (SNV) and Multiplicative Scatter Correction 
(MSC): these methods correct differences in the path length and baseline offsets in 
particle size distribution reflectance spectra. The advantage of MSC over SNV is 
that the processed spectra retain the original magnitude of the Y scale whereas the 
SNV transformation requires a mean subtraction, which results in spectra centred 
about the zero axis. Both methods can be used to process transmission spectra [94-
96].  
The hyperspectral image cubes can be processed using univariate or multivariate data 
analysis. Depending on the chemical and physical properties of the investigated sample 
different data modelling approaches can be used as authors have reported analysing data 
from pure substances and binary mixtures using either the intensity of single wavelength 
[86, 98-101],  correlation coefficients or peak-height ratios [99, 102]. Univariate methods 
use one measurement per sample (either peak height or peak area). Reference spectra and 
calibration sets are required to perform qualitative or quantitative data analysis such as 
identifying an isolated peak in the spectra. The created univariate model is optimised by 
Least Squares Regression techniques [95, 103].  
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Another approach in data modelling is spectral matching (compare correlation). This 
method produces an image with values ranging from 1 to 0, where the value 1 means 
perfect correlation. Each region of the chemical map is assigned to a sequence of colours 
e.g. blue, light blue, green, yellow, red. The colours represent the level of correlation of the 
investigated image sample with the reference material. This type of image is presented as a 
false coloured image. Good correlations values have a range from 0.99 to 0.80 (assigned as 
red on the image colour bar) and indicate the regions in the image belonging to certain 
reference material in the spectral library to which it’s compared. Consequently, the blue 
areas on the image correspond to very low correlation values for a particular material and 
indicate its absence in the area of the investigated material [96, 104, 105].   
Reduction of variables by Principal Component Analysis (PCA) is another approach to the 
modelling of imaging data. PCA is a mathematical procedure which reduces the spectral 
data into scores (scaling constants for spectral variations for example concentration of 
constituents) and loadings (number independent variations occurring in the spectral data 
like constituents of the sample, detector noise, possible inter-constituents interactions, etc). 
The number of principal components of the sample can be calculated. The reduced data can 
be used further for calibration modelling [96, 106]. Quantitative analysis of the data can be 
achieved by using a multivariate calibration approach on the set of samples. Addition 
calibration standards, which are representative of the analysed samples must be selected to 
determine the reference values and are related to spectral variations of the analysed 
analytical target. The model can be validated by cross validation or using an independent 
validation set [94, 96].  
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In the case of complex mixtures, multivariate approaches have generally proved to be more 
beneficial since more information is extracted about analysed samples than with univariate 
methodology. Published work includes data analysis methods like: principal component 
analysis (PCA) [102, 107-110], classical least squares (CLS) [100, 111], partial least 
squares (PLS-1 for linear methods, PLS-2 for non-linear methods) [107, 109, 111-114] and 
multivariate curve resolution (MCR) [115, 116]. Processing the data using different data 
analysis methods can provide different chemical information from analyzed sample images 
[117].  
In this study NIR Imaging was used to determine the distribution of the components in the 
solid dosage form, the collected data was pre-processed and a PLS-2 model built.  
 
 
 
 
 
 
 
 
 
 58 
2.2.2.4 Applications of NIR imaging 
NIR spectral imaging provides a rapid approach for acquiring high-resolution spatial and 
spectral information on pharmaceuticals. It is a technology capable of providing an in-sight 
into the structure and function of modern solid dosage forms. It combines the capability of 
spectroscopy for molecular analysis with the power of visualization affording precise 
characterization of the chemical composition, domain structure, and chemical architecture. 
A NIR Chemical Imaging spectrometer is a solid state system without movable parts so 
often no calibration of the system is required, the presence of filters allow for specific 
wavelength image acquisition. There is no need for liquid nitrogen to cool down the system 
as focal plane array detectors can use electronic cooling to reach the conditions of liquid 
nitrogen operating temperature. The system allows for imaging of a wide range of samples 
without previous preparation including samples with uneven or shiny surfaces since the 
specular glare is removed by polarizers [91, 92]. The technique is useful in the investigation 
of blend uniformity, raw material and impurity detection and identification [84, 91], 
pharmaceutical solid dosage form analysis, tablet deconstruction, the content of moisture in 
excipients or wet granulation mixture as well as in determination of different fabric types 
and  animal feed studies [84, 91, 114, 118, 119].  
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2.2.4 Chemometric data analysis 
The interdisciplinary field which involves using analytical chemistry, multivariate statistics, 
computer science and mathematical modelling is called chemometrics. Application of this 
data analysis provides a possibility to extract from the analytical data; maximum chemical 
information, optimization of experimental procedures and chemical measurements and also 
significance testing as well as calibration and validation of the analyzed data sets [94, 95, 
97].  
In this project PLS and MCR analysis was used to extract additional information from the 
spectroscopic data. 
 
2.2.4.1 Partial least squares (PLS) 
Partial Least Squares data analysis is a quantitative spectral decomposition technique for 
multivariate data. PLS is a regression method for constructing predictive models. It takes 
into account errors in both the concentration estimates and the spectra. The technique 
decomposes spectral and concentration data at the same time (Fig 2-8). In effect this 
generates two sets of vectors and two sets of corresponding scores; one set for spectral data, 
and the other for the constituent concentration. As every new factor calculated for the 
scores is “exchanged” the contributing factor is removed from the data. The reduced 
matrices are then used when calculating the next factor. The process repeats until the 
appropriate number of factors is calculated [94, 96].  
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Fig. 2-8 Scheme of the PLS decomposition process [96].  
There are two versions of the PLS algorithm; PLS-1 and PLS-2. The PLS-2 algorithm 
calibrates for all the constituents simultaneously, which means that the results of spectral 
decomposition give one set of scores and one set of eingenvectors for the calibration. 
However the calculated vectors are not optimized for each individual constituent. On the 
other hand the PLS-1 algorithm calculates a separate set of scores and loading vectors for 
each constituent of interest which should give more accurate predictions, but the time taken 
for the data analysis is increased [96, 103].   
 
One of the most difficult tasks is determining the right number of loading vectors (factors) 
to use to model the data. If too few vectors are used to construct the model there will be a 
lack of prediction accuracy for unknown samples, this is known as under-fitting. If the 
number of factors gets too large, which will include noise from the data, the model will fit 
the sampled data perfectly but will fail to predict new data well, this is called over fitting. 
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Therefore it is important to define a model that contains enough vectors to properly model 
the components of interest without adding to much contribution from the noise.  
 One of the most effective methods to calculate the number of factors is PRESS ( Prediction 
Residual Error Sum of Squares). PRESS is calculated by building the calibration model 
with the number of factors, then predicting some samples of known concentration against 
the model.  
    PRESS Cp Ci j i j
j
m
i
n
 

 ( ), , 2
11
 
n- number of samples, m- number of constituents, Cp- matrix of predicted sample 
concentration, C-matrix of known concentrations. 
The smaller the value of PRESS, the better the prediction for a random effect model with a 
value of 0 indicating perfect prediction [120]. However, during the selection of number of 
factors (apart from the PRESS value) the number of components in the sample needs to be 
considered.  There are a variety of methods which can be used to validate the model, like 
self –prediction, leverage or cross validation [96, 97, 121].  
   
There are several advantages of the PLS methodology compared to PCA: 
1) the eingenvectors are directly related to the constituents of interest rather than largest 
common variations 
2) calibrations are usually more robust providing that the calibration set accurately reflects 
the range of variability expected in unknown samples 
3) the technique can be used for very complex mixtures when knowledge about constituents 
of interest is required 
4) sometimes it can be used to predict samples with constituents (contaminants) by 
modifications of the SIMPLS algorithm [122]. 
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There are also PLS disadvantages, which involve longer calculations than in other classical 
methods, generally a large number of samples are required for accurate calibration and the 
samples for the calibration set must avoid co-linear constituent concentrations [96, 123]. 
 
 2.2.4.2 Multivariate curve resolution analysis (MCR) 
Multivariate Curve Resolution – Alternating Least Squares (MCR-ALS) - this iterative 
method finds the matrices of concentration profiles and instrumental responses. 
Multivariate curve analysis works by considering that the response matrix D containing raw 
measurements of all the components present in a data set can be separated into two 
matrices, one containing the pure normalised spectra (factors) and the other containing 
intensity information (scores).  All the real spectra can then be considered as a linear 
combination of the factors and their scores. This is usually achieved by using methods like 
constrained least squares optimisation process [94].   
Both matrices S (factors) and C (scores) (Fig. 2-9) are optimized at each cycle, none of 
them has a priority, The general operating procedure includes: determining the number of 
compounds in matrix D, calculating initial estimates, using the estimate C to calculate 
matrix S, using the estimate S to calculate matrix C, and from the product of C and S 
calculate and estimate the original data matrix D [94, 124]. 
 
 
 63 
 
Fig 2-9 Scheme of MCR 
 
During analysis it is often necessary to impose some defined limits such as forced zero to 
eliminate negative bands which have no physical meaning and an equality constraint to 
force all the variance into the scores matrix.   
Although rotational ambiguity and noise are the two main sources of uncertainty in the 
multivariate curve resolution data analysis, the degree of selectivity of components from 
complex mixtures depends on the amount of band overlap in the region of interest from 
certain components with other constituents and from the distribution of the different 
components in the data set [125, 126]. Additional spectra of standards to data matrices are 
one way to avoid influence of rotational ambiguity. 
MCR is widely reported as a desirable method of data analysis in biochemical processes 
like protein folding or protonation, environmental data analysis and complexion of nucleic 
acids [94]. 
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2.2.5 UV/visible spectroscopy 
Ultraviolet spectroscopy can provide quantitative information about investigated materials 
for monitoring kinetic reactions. A UV spectrum is often used as an identity check for the 
standard materials. UV/visible radiation is electromagnetic radiation combining all the 
wavelengths from the ultraviolet and visible region of the electromagnetic spectrum 
wavelength from 200 to 700 nm [127].  
 
2.2.5.1 Principles of UV/visible spectroscopy 
Radiation in the UV/visible is absorbed through the excitation of electrons involved in 
bonds between particular atoms of the molecule. If in the molecule the double bonds are 
present in the conjugated form; two or more double bonds separated by a single bond, so 
called chromophore system, the UV absorption will take place at the longer wavelength and 
with higher intensity.  
UV/visible spectroscopy follows the Beer-Lambert law discussed in details in the section 
2.2.1.4.1   
 
2.2.5.2 Instrumentation 
UV/visible spectrophotometer include a light source, which is usually a deuterium lamp for 
UV region from 190-350 nm, and quartz halogen or tungsten lamp for the visible region 
from 350-900 nm. The radiation passes through slits to reach a monochromator, which 
disperses the light to the constituent wavelengths further selected by a slit. The 
monochromator can be rotated so the full range of wavelengths is passed through the 
sample in the quartz cell whilst the instrument scans across the spectrum. The absorbed 
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radiation is reflected to the detector. A blank solution can also be used to correct for the 
background reading in the sample spectrum.  
 
2.2.5.3 Applications  
UV/VIS spectroscopy is a robust and commonly used method for the quantification and 
characterization of materials, it can also be used indirectly to determine the pKa values for 
drugs and the solubilities of substances. UV-vis spectroscopy is widely used in dissolution 
apparatus to detect drug release from formulations and to monitor degradation products of 
the drug in the solution. It is a relatively cheap and easy-to-use method for making 
quantitative measurements and routine analysis.  
The technique cannot be used easily in the case of complex mixtures and its selectivity 
depends on the chromophore of the material [127, 128].  
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2.2.6 Dissolution testing 
Drug release in the human body can be measured ‘in-vivo’ by measuring plasma or urine 
concentrations in the subject concerned. However, there are certain obvious impracticalities 
involved in employing such techniques on a routine basis. These difficulties have led to the 
‘in-vitro’ tests which are now the basic type of dissolution testing. Tablet dissolution is a 
standardised method for measuring the rate of drug release from a dosage form. The 
principal function of the dissolution test may be as follows: 
      • Optimisation of therapeutic effectiveness during product development and stability 
assessment. 
      • Routine assessment of production quality to ensure uniformity between production 
batches. 
      • Assessment of ‘bioequivalence’, that is, production of the same biological availability 
from discrete batches of products from one or different manufacturers. 
      • Prediction of ‘in-vivo’ availability [27, 129]. 
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2.2.6.1 Instrumentation 
Many different types of equipment have been developed for measuring dissolution rates. 
The solid state properties (e.g. morphology of the material) play a crucial role on the 
dissolution behaviour of a solid system. Also the dissolution media (most often phosphate 
buffer) may have an impact on the behaviour of the solid material, and these changes may 
alter the dissolution behaviour of the drug formulation/substance. Typical examples of 
these changes are alterations at the molecular level (polymorphic changes), re-
crystallization or formation of hydrates/ solvates. A result of dissolution measurement is the 
concentration of the drug in the dissolution medium. With conventional dissolution 
apparatus (Fig 2-10) the liquid medium is pumped out of the vessel and measured with a 
UV-Vis spectrophotometer every 3 min. In case of sensitive measurements other 
specialized techniques like fibre optics can be used.  
 
Fig 2-10 Schematic of the dissolution system apparatus [130] 
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Fig 2-11 The dissolution vessels with mixing apparatus, I) baskets, II) paddles [130] 
The basket (USP apparatus 1) as shown in Fig 2-11, consists of a stainless steel wire basket 
(approximately 25 mm diameter x 37 mm high 40-mesh) rotated at constant speed. The 
tablet is placed in the closed basket and all the samples at the same time are placed into the 
media in the vessels with at a constant temperature 37
o
C. The measurements are collected 
during the experiment in real time.  
In this project the Dissolution testing method was used in order to determine drug release 
from the analyzed formulation [87, 130].   
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3. Optimization of the compaction process 
 
Pharmaceutical formulations are multicomponent systems consisting of the active 
substance and a number of functional excipients like binder, disintegrant, lubricant, filler 
and glidant. During the early stage of method development it is critical to ensure the 
content uniformity of the investigated mixture. Apart from the chemical purity of the active 
substance and other ingredients, the physical properties of raw materials such as crystal 
form, particle size, moisture content and density need to be considered as these factors 
affect the mixing efficiency, determine the selection of the mixing method and influence 
the kinetics of drug release. The homogeneity of distributed components in the 
pharmaceutical formulation are important to ensure the final tablet quality [46, 131, 132]. 
The compressibility characteristics of powders and their tableting process require further 
exploration of the compaction force range suitable for certain formulation and appropriate 
tooling for the compression equipment. 
 
A significant body of literature has been written about the subject of optimization 
parameters for pharmaceutical method development of solid dosage forms containing 
hydrophilic matrices [25, 101, 133-139]. Nokhodchi (1995) investigated the influence of 
different viscosity grades of HPMC, particle size and compression force on the HPMC 
compaction process [29, 140], whilst  Velasco (1999) discussed the significance of particle 
size and compression force of the selected drug and HPMC formulation in dissolution 
studies [28]. Over the years, research has also concentrated on more complex mixtures, 
where the optimization of formulation development and its compaction process is more 
challenging [129, 141, 142]. 
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The first experimental part of this project concentrated on optimizing the preparation, 
process and parameters for the proposed content of the formulation and is discussed in this 
chapter.  
 
3.1 Aims: 
 To optimize the preparation process of proposed pharmaceutical formulations 
ensuring the content uniformity of the mixtures  
 To manufacture reproducible tablets in situ on the ATR crystal and build a PLS 
model to predict the concentrations of particular excipients of the analyzed 
formulation   
 To confirm the distribution of the components in the tablets using imaging 
techniques 
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3.2 Materials and methods: 
3.2.1 Materials 
Materials used in this Chapter are detailed in Chapter 2, section 2.1 
3.2.2 Preparation of the mixtures  
Formulations were prepared according to proposed concentration values listed in Table 3-1.  
Formulation of HPMC and citric acid 
HPMC Citric acid 
95 
90 
80 
50 
5 
10 
20 
50 
 
Table 3-1. Composition of binary formulations derived from HPMC and citric acid 
mixtures 
3.2.2.1 Mixtures of powders with unmatched particle sizes 
Every formulation was mixed in three different ways; manual shaking (1 min), tumble 
blending (5 hrs) and grinding (2 mins) to optimize the mixing conditions for the 
formulation. The total mass of each mixture tested was 33.3 g. 
 
3.2.2.2 Mixtures with particle sizes less than 106 microns 
Citric acid was ground and sieved manually (the size of the sieve <106 microns) to produce 
a particle size range comparable to that of sieved HPMC (sieve <106 microns). The sample 
was placed on the 20 cm diameter, stainless steel sieve.  
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Four formulations with the composition shown in Table 3-1 were prepared using tumble 
blending for 15 min as a mixing method. The total mass of every mixture was 5 g. 
3.2.3 Mixing procedures used to prepare formulations  
3.2.3.1 Manual shaking 
The mechanical stress caused by the shaking process is one of the methods that one could 
use to mix two or more substances. However, the effect of manual shaking depends on the 
materials used in a formulation, what may result in forming aggregates (conjunction of the 
particles into the mass)  in the mixtures could have significant influence on the release of 
drug from the formulation (decreasing rates or more rapid release at different time points 
during the experiment) [143].  
 
3.2.3.2 Tumble blending 
The most common approach in industry is the use of tumble blending to homogeneously 
mix substances. Possible problems may occur with potential over- or under-blending of the 
mixture. Over-blending can affect the hardness of the tablet or retard the dissolution rates 
whilst the under-blending can cause compaction difficulties including reducing the 
compression rate or the tablet sticking to the punch [131, 144]. In this project a Stuart 
Rotordrive STR4 homogenizer was used to blend the samples. A hollow container with a 
mixture was attached horizontally to the rotating shaft for the required amount of time.  
 
3.2.3.3 Grinding  
This technique of mixing reduces the particle size of the components, it can lead to changes 
in the crystalline structure of the substances, improve the molecular interactions in the 
mixtures and enhance the solubility along with dissolution rates as required [145, 146].  
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The analyzed formulations were manually ground using a pestle and mortar for the 
predetermined time. 
 
3.2.4 Compaction process 
The tablets were manufactured using the direct compression approach. The dry mixture of 
powders was compacted directly in situ on the ATR crystal, using an appropriate 
compaction cell.  
 
3.2.4.1 Design of compaction cell 
The design of the compaction cell for this project was based on Kazarian’s published 
studies and reproduced with permission [147, 148]. 
 
Photo 3-1.Top view of the compaction cell used for the hydration studies. 
 
The compaction cell consists of three parts: brass base plate – diameters 36 x 32 x 12 mm (l 
x w x h), sleeve and stainless steel punch.  The plate contains a 10 mm threaded internal 
hole, positioned slightly off-centre (1.5 mm). A 3 mm hole is drilled into the centre of the 
sleeve and forms the die for the tablet. The predetermined mass of powder is pressed using 
the ~3 mm diameter stainless steel punch. To generate the controlled force on the sample 
the torque screw is applied. 
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 3.2.4.2 Creating tablets in situ on ATR crystal 
 
The compaction cell experimental setup 
 
 
 
 
 
Fig. 3-1. Scheme of experimental setup: compaction cell, sample and ATR accessory. 
 
The compaction cell is positioned at the center of the ATR unit, so that the created tablet 
covers the whole surface of the ATR crystal. Measurement is made at 37 
o 
C. The system is 
settled by the lower “o’’-ring being compressed by the sleeve. The spectrum of the sample 
is recorded at spectral resolution 8 cm
-1
, with 100 scans.  
The pressed sample was kept in position and spectra were collected after 5 and 10 minutes. 
Whilst the tablet is still under compression by the punch, the ring is lifted, and a spectrum 
of the tablet is recorded again.  
 
All spectra were collected and analyzed by a Thermo Nicolet Nexus FTIR spectrometer 
controlled by Omnic 6.1 software. The data were collected at resolution 8 cm
-1
, and were 
the result of the average of 100 scans over the spectral range 4000-750 cm
-1
.  
 
 
 
 
punch 
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3.2.4.3 Parameters for the tablet compaction 
Mixtures of components with unmatched particle size - the powders were compacted on the 
ATR crystal and the results from the 90 and 120 [cN.m] torques were compared to 
investigate possible variations on the compaction pressure and determine any final 
properties of the investigated tablets. The total compaction time for each tablet was 10 min, 
the weight of each compact 20 mg. From each compositional mixture prepared with three 
different mixing procedures 6 tablets with force 90 [cNm] and another 6 tablets with force 
120 [cNm] were created 
Mixtures with particle size less than 106 microns -  samples were compacted on the ATR 
crystal with a controlled force of 90 [cN.m] torque. The total compaction time per tablet 
was 10 min, and the weight of each compact 10 mg. From each blended mixture 6 tablets 
were manufactured.  
 
The results of the experiments will be described using the example of the 80% HPMC and 
20% citric acid composition (HC80/20) as all other mixtures showed similar tendencies in 
results obtained.  
 
3.2.5 PLS analysis 
The sample spectra in a spectral range 4000-750 cm
-1
 generated in the compacting process 
(after raising the ring walls) were divided randomly into two sets. The calibration set 
contained 4/6 of the total amount of the spectra; the validation set 2/6. The calibration set 
was created in order to establish the PLS model whilst the remaining data were used to test 
the model.  The data were preprocessed as discussed in Chapter 2 section 2.2.3, to create 
the PLS model.  
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3.2.6 NIR analysis 
The NIR Chemical images were acquired using the Spectral Dimensions Sapphire 2450 
Imaging System. Spectra were collected from 1400-2400 nm in steps of 10 nm with 16 co-
added scans at each wavelength range. Six tablets selected randomly from each batch were 
placed on a mirrored slide during data collection to eliminate background when processing 
the data. A background and “camera dark image’’ were collected using the same 
parameters as the images.  
Data were analyzed using ISys 
TM
 3.1 (Spectral Dimensions, Inc.) chemical imaging 
software. To determine reflectance in the data preprocessing stage the camera dark cube  
(image of the dark background) (D) was ratioed against the subtracted sample image (S) 
and the white background (B) image was ratioed against the subtraction the camera dark 
cube (D). The next stage of data preprocessing was the conversion of reflectance ® to 
log(1/R).  







R
A
1
log     where          
 
 DB
DS
R


    eq(3.1) 
 
The applied spatial mask eliminated pixels coming from outside tablet area. The 
multiplicative scatter correction (MSC) of spectra was achieved by mean centring and 
normalization to correct for path length and thickness differences at each pixel. In the next 
step a second derivative was applied. The standard substances image cubes were processed 
and data were saved in the library [108].  
The preprocessed data were used to build a PLS-2 model. The amount of possible principal 
components (PC’s) in the sample was selected and the appropriate separation of 
components was applied. The classification (concentration) images for analyzed principal 
components were created. 
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3.3 Results and discussion 
3.3.1 Effect of different mixing procedures and particle size on the reproducibility of the 
samples 
The homogeneity of the mixtures is one of the critical conditions to ensure reproducibility 
of the manufactured tablets. There are many factors that influence the content uniformity of 
compacts, the most important of which are the particle size of the components and the 
preparation of the formulation. In this project different mixing methods and particle size 
matched versus unmatched particles were compared. 
 
3.3.1.1 Mixtures with unmatched particle size of the powders 
 
FTIR spectra of the compacted tablets from composition HC80/20 (Fig. 3-2) showed a 
variation of intensity between individual spectra in each set of samples, as well as variation 
of the shape of the bands. The highest level of agreement between samples from the same 
set was observed in the case of tablets created with torque 90 [cN.m] from previously 
tumble blended samples, however this result still didn’t provide the required level of 
reproducibility. From the six spectra generated from this formulation, two showed 
significant differences to the other four. This would significantly influence the quality of 
any further data analysis carried out (e.g. PLS). 
Spectra collected from the composition 80% HPMC 20% citric acid (Fig 3-2) from all 
investigated methods of mixing showed a disproportionally strong intensity of bands 
associated with citric acid. In fact if one would consider the comparison of the pure citric 
acid spectrum and the generated mixture spectra the resulting similarity between them 
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could suggest that in the formulation spectra the main component with the highest 
concentration value present would be citric acid.    
 
 
Fig. 3-2. FTIR spectra of the formulation containing 80% HPMC and 20% Citric acid (HC80/20) 
spectra a), d) represent tablets obtained from manually shaken mixtures, b), e) samples from tumble 
blended mixtures, c), f) spectra of tablets from ground mixtures.  
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The citric acid was present in its crystalline form in the formulation HC80/20. It is known 
that citric acid in its crystalline form is a substance with a low level of compressibility in 
contrast to the highly compressing HPMC powder. The variability was caused in the non-
uniformity of the mixture due to the particle size of that component being significantly 
larger in comparison to the polymer. This difference also had an influence for the efficiency 
of formulation mixing and as a result for the compaction process. The obtained results 
obviously suggest the presence of heterogeneity in the analysed mixtures. 
 
3.3.1.2 Mixtures with particle size less than 106 microns 
The raw FTIR spectra for each compaction tablet from the formulation HC80/20 
composition are shown in Fig. 3-3.   
 
 
Fig. 3-3. FTIR spectra from blended mixture of HC80/20 with controlled particle size. 
The infrared spectra recorded showed a highly level of similarity in shape, intensity and 
position of bands. The spectra of tablets can be overlaid and all components can be readily 
discerned. The characteristic band ~1100 cm
-1
 γ(CO) due to the presence of HPMC is 
observable as are the characteristic bands associated with γ(OH) ~3000-3100 cm-1 of the 
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citric acid. The matching of particle size within the composition had significantly improved 
the reproducibility of infrared spectra.  
 
3.3.2 Effect of different mixing procedures and particle size on the prediction of 
concentration values.  
The quantitative analysis of samples very often involves the modeling of the data in order 
to predict concentrations. There are numerous examples in the literature published about 
the use of partial least squares (PLS) data analysis to predict the concentration of 
components in the analyzed sample.  
PLS-2 has extensively been used in this project to determine homogeneity and 
reproducibility of the compaction process.  
 
 3.3.2.1 Mixtures with unmatched particle size of the powders 
The application of PLS to the FTIR data, has been used to quantify excipients within the 
compacts. The PLS model selection criterion involved the cross-validation method. The 
samples were divided into two sets; calibration set (12 samples) and prediction set (8 
samples). The data were preprocessed using path length correction, mean centering, and the 
NIPALS algorithm was used for optimization. The independent sample was included in the 
data to test the model.     
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Results for tablets made from shaken mixtures 
a)   90 [cN.m}                                                      b) 120 [cN.m] 
 
Fig 3-4. Plot of calculated (from PLS model) versus actual concentration levels.  
Mean and standard deviation for two components used in shaken samples for certain actual 
concentration values. 
a) 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev 
50 71.0 50 29.0 3.74 
80 74.0 20 26.0 8.00 
90 86.2 10 13.8 10.92 
95 79.2 5 20.8 3.89 
 
b) 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev 
50 71 50 29 3.74 
80 74 20 26 8.00 
90 86.2 10 13.8 10.91 
95 79.2 5 20.8 3.89 
Table 3-2(a,b) Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the manual shaken samples. 
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Results for tablets made from blended mixtures    
a)   90 [cN.m}                                                      b) 120 [cN.m] 
 
Fig 3-5. Plot of calculated (from PLS model) versus actual concentration levels.  
Mean and standard deviation for two components used in blended samples 
a) 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev. 
50 58.50 50 41.50 12.61 
80 77.87 20 22.13 8.13 
90 87.97 10 12.03 8.73 
95 93.61 5 6.39 5.25 
 
 b) 
Table 3-3(a,b) Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the blended samples. 
 
 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev 
50 73.81 50 26.18 5.89 
80 74.18 20 25.81 7.03 
90 81.61 10 18.39 8.34 
95 85.47 5 14.52 5.70 
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Results for tablets made from ground mixtures    
a)   90 [cN.m}                                                      b) 120 [cN.m] 
 
Fig 3-6. Plot of calculated (from PLS model) versus actual concentration levels.  
Mean and standard deviation for two components used in grinded samples 
a) 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev 
50 68.55 50 31.45 9.07 
80 82.59 20 17.41 9.20 
90 82.09 10 17.91 7.90 
95 86.39 5 13.61 15.78 
 
b) 
concentration of HPMC [%] mean HPMC [%] concentration of citric [%] mean citric [%] st dev 
50 51.20 50 48.79 2.60 
80 82.16 20 17.83 6.79 
90 87.92 10 12.08 3.21 
95 93.38 5 6.62 5.20 
Table 3-4 (a,b) Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the ground samples. 
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indicated a high standard deviation in the compositions of the tablet surface. Changing the 
number of factors (the used one was two) didn’t improve results. Low R2 values for 
analyzed samples, confirm that the data do not fit well with the developed model. The 
application of different mixing types didn’t provide a uniformity of the mixtures. Manual 
shaking mixtures provided the most variability of the predicted values, probably because 
the samples were mixed manually for only a short time leading to an ineffective method of 
mixing. Tumble blending showed better predicted values of the components however the 
length of time which the sample was mixed and influence of particle size still potentially 
lowered the chance of getting reproducible tablets. One of the most reproducible results 
was generated from the ground samples which were compacted with 120 [cNm] torque 
value. The slightly better reproducibility is explainable considering the fact that during the 
grinding of the mixture the particle size of citric acid was modified to that approaching the 
HPMC one. The high value of torque applied also ensured better compaction of the 
samples.  
3.3.2.2 Mixtures with particle size less than 106 microns 
To try to improve the PLS model samples were prepared by reducing the particle size of the 
components within the mixture prior to blending. 
 
 
 
 
 
Fig 3-7 Plot of calculated (from PLS model) versus actual concentration levels for citric acid and 
HPMC. 
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The samples selected for PLS modelling were divided into two sets; for the calibration set 
12 samples and for the validation set 8 samples. The preprocessing of the data undertaken 
included path length correction and mean centering, which is same for all sets of data in the 
project. Before constructing the model optimal calculation of the number of principal 
components present in the sample is crucial, as selection of the incorrect number of factors 
can lead to over fitting or under fitting. If the number of factors is more than the number 
required for the sample, more noise will be added to the model. If the number retained was 
less than required, there is a risk of ignoring meaningful data for the calibration [149, 150]. 
  
Mean and standard deviation for two components used in blended samples 
concentration of citric [%] mean citric [%] concentration of HPMC [%] mean HPMC [%] st dev. 
50 48.48 50 51.52 2.55 
20 21.21 80 78.79 2.73 
10 8.67 90 91.33 1.91 
5 5.26 95 94.73 2.34 
Table 3-5 Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the samples. 
 
The data (Fig 3-6) fitted well into a PLS linear model, using two factors for the analysis, 
showing good resemblance of generated pure component spectra with real ones and 
obtaining high R
2
 values. As indicated previously the plots show the predicted versus the 
actual concentration, within the individual data points having an excellent grouping and 
similarity to the actual concentration values. The results for the HPMC model show the 
slightly better fit than citric acid, as there is less variability in the predicted values of 
concentrations.  The analysis confirmed significant improvement in terms of reproducibility 
compared to the previous models.  
The predicted concentrations values of the sample components were compared with the 
actual concentrations and used to calculate the Root-Mean-Square Error of Cross-
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Validation (RMSECV). The RMSECV indicates the precision and accuracy of 
predictions[94].  
 
 


n
i
kii
n
yy
RMSECV
1
2
,
      eq(3.1)        
where n – number of calibration samples  
          yi – predicted value 
          yi,k – actual value 
The further detailed data analysis is discussed in Chapter 4.  
 
3.3.3. Effect of particle size on the distribution of the components in the tablet 
 
The evolution of the tablet structure during the compaction of the components is controlled 
by the compression mechanics of the particles, their dimensions and also the fracture 
toughness and tensile strength. It has been reported that the distribution of the particle size 
is an important factor for the processing behavior of a powder during pharmaceutical 
manufacturing. It also has an effect on the tablet forming ability of a powder. Also the 
distribution of the particles in the pharmaceutical tablet has a significant influence on the 
drug release profile [101, 107, 151, 152].  
Therefore in this section the distribution of components in the analyzed tablets will be 
discussed. 
 
3.3.3.1 Mixtures with an unmatched particle size 
 
During the optimization process and the development stage it is crucial to achieve an 
understanding of the formulation and the possible physical and chemical interactions 
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within. The analysis of the tablets made from unmatched particle sizes was conducted in 
order to check the homogeneity of the formulations and observe any possible changes in 
chemistry on the surface of the tablet.  
The analysis was performed according to parameters described in a Chapter 3 Section 3.2.6, 
with the weight of tablet being 20 mg. 
Results showing the set of six images collected from manufactured tablets using powders 
manually shaken. 
a)  Citric acid distribution                             HPMC distribution 
 
Fig. 3-7. NIR images of tablets prepared by manually shaking binary mixture HC80/20 of 
citric acid and HPMC using, a) torque 90 [cN.m], b) torque 120 [cN.m] applied pressure. 
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Results showing the set of six images collected from manufactured tablets using powders 
blended. 
a)  Citric acid distribution                             HPMC distribution 
 
Fig. 3-8. NIR images of the tablets prepared by blending binary mixture HC80/20 of citric 
acid and HPMC using, a) torque 90 [cN.m], b) torque 120 [cN.m] applied pressure. 
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Results showing the set of six images collected from manufactured tablets using powders 
ground. 
a) Citric acid distribution                             HPMC distribution 
 
Fig. 3-9. NIR images of the tablets prepared by grinding binary mixture HC80/20 of citric 
acid and HPMC using, a) torque 90 [cN.m], b) torque 120 [cN.m] applied pressure. 
 
NIR images of the tablets are chemical maps of the surface with a spatial resolution of 
25μm. The colour bar on a right side of the image shows the concentration of the substance; 
red represents the highest concentration and blue shows the lowest concentration of the 
substance. The results of the NIR images collected from manually shaken citric acid and 
HPMC (Fig 3-7) indicate a somewhat heterogeneous surface with large aggregates of both 
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components. The components are not mixed well enough to ensure the reproducibility of 
the results within the same batch. 
The classification scores collected from the tumble blender formulation (Fig 3-8) also are 
following the “heterogeneous path” of the poorly distributed components on the surfaces of 
the tablet. Critically, in the case of these images is visible defragmentation of the samples 
which is affected by the particle size but also poor compressibility of the citric acid. For the 
ground samples (Fig 3-9) the NIR images of the surface structure shows a range of 
aggregate sizes for the components. It confirms the heterogeneous distribution of the 
excipients. This could suggest that grinding has changed the particle size of the components 
and also the compressibility of powders independently of the pressure applied. 
 Most of the NIR images show a higher proportion of HPMC than would be expected. As 
this excipient has a visibly smaller particle size than the citric acid, and as the images were 
acquired from the lower face of the compaction, it seemed likely that the results were 
affected due to segregation of the HPMC to the bottom of the compaction cell. This 
however was not supported by the FTIR data where citric acid gave a much stronger 
response in the mixtures.  
 There were a few possible explanations of the formulation behaviour; 
1. Citric acid was being lost at the point of sampling - small flat faced spatula was 
used to sample the bulk blend, which could increase the likelihood of the loss of larger 
crystalline particles during the sampling process.  
2. Due to the longtime of tumble blending segregation may be occurring within the 
bulk blend maybe occurring immediately after blending was stopped. This could result in 
the heterogeneous mixture being sampled for the compaction and the disproportionate 
presence of HPMC measurements compared to citric acid.  
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3. The powder at the end of the ATR compaction process can easily spread around the 
ATR crystal (changing the surface of the tablet) during the dismantling of the equipment, 
probably due to the relaxation of the HPMC particles once the metal punch is no longer 
applying pressure. 
4.         During the compression process the segregated mixture may cause the bigger size 
particles of citric acid to fall to the bottom of the sampled powder in the die, this theory the 
resulting ATR spectra from the compaction experiments seem to confirm. 
The problems which occurred during the experiments with discussed formulations could be 
resolved by changing parameters of mixing procedure, particle size of the excipients 
providing better compressibility of the samples and the components distribution. 
 
3.3.2.2 Mixtures with particle size less than 106 microns 
The strong presence of aggregates in the tablets with unmatched particle size suggested that 
changing the particle size of the components used will make it possible to identify the best 
methods to mix formulations. The applied parameters with reduced amount of tumble 
blending time on the formulation allow the generation of more homogeneous tablets. 
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Results showing the set of six images collected from manufactured tablets using powders 
with matching particle size blended. 
 
Citric acid distribution                             HPMC distribution 
 
Fig. 3-10. NIR images of the tablets prepared by blending binary mixture HC80/20 of citric 
acid and HPMC using torque 90 [cN.m] applied pressure, the mixed powders matching the 
particle size. 
The NIR images (Fig 3-10) show the two principal components present in the tablet within 
a formulation. A significantly more homogeneous surface confirms that the preparation of 
pharmaceutical formulation with an uncontrolled particle size of the components can be 
challenging. The uniform distribution of the citric acid compared with the previously 
discussed results (Fig 3-8 and 3-9) indicates that the modification of the particle size and 
the blending time allowed us to obtain samples with an acceptable level of reproducibility 
and content uniformity This result was supported by the PLS analysis and ATR spectra. 
The NIR images show also presence blue circles what suggest the edge effect, what could 
influence the spectral data collection. However to investigate further presence of edge 
effect the Infinity Focus Microscope technique which could provide the topographical 
information would need to be applied. 
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The generated results during the optimization process provided valuable information about 
the physical solid state behaviour of the investigated powders. The chemical properties of 
the excipients and possible interactions within the formulation will be discussed in the next 
section of this work.  
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3.4 Conclusions 
In the early stage of new drug method development, the optimization of the parameters for 
a reproducible manufacturing process of the formulation is the most critical issue. In this 
chapter experiments were conducted testing the effect of different mixing procedures, 
(manual shaking, tumble blending and grinding) and variability of particle size on the 
uniformity of the formulations determined by FTIR-ATR with PLS data analysis and NIR 
imaging. The prepared formulations of HPMC and Citric acid showed that the samples 
without matching particle size and mixing procedure had a high degree of heterogeneity. 
The presence of component aggregates on the surfaces of analyzed samples determined by 
NIR confirmed the low level of uniformity of the tablet images generated by NIR chemical 
imaging and also explained the within-batch differences observed for spectra obtained from 
the same composition using the diamond ATR crystal and compaction cell. The PLS data 
analysis showed a large degree of variability between the predicted values of concentration 
when compared with the actual ones used for the preparation of the formulations.  
It was observed that the particle size dimensions and the degree of variability had a 
significant impact on experimental data in terms of reproducibility and heterogeneity of the 
samples. The differences in the results obtained using three different mixing procedures 
suggested that the appropriate time and technique used to mix powders can provide 
significant improvement of the uniformity of the pharmaceutical formulation. 
 
The optimal tablet reproducibility and homogeneity of components has been achieved by 
controlling the particle size of the substances used for mixture preparation. The samples 
were compacted in situ on the ATR crystal in a compaction cell which proved to be a 
successful tool in a small scale tablet manufacturing process. The variation in the intensity 
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of FTIR-ATR spectra, PLS analysis and NIR Imaging confirmed homogeneity of the 
manufactured samples as well as possibility of creating lab scale reproducible tablets. 
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4. Investigations of solid dosage form: binary 
formulations. 
Solid state reactions in formulations and drug substances may include chemical reactions, 
solid state phase transformations, dehydration and desolvation. Particular interest is usually 
directed to the drug-substance which can react with other excipients of the formulation. The 
main aim of understanding the solid pharmaceutical system is to prevent possible 
unnecessary reaction of the active substance and at the same time improve the stability of 
drug substances and the medicinal products. However if the drug substance does react in a 
certain formulation in the solid state then the process needs to be analyzed and corrected. In 
the first step possible water absorption and increased molecular mobility needs to be 
considered following the possible molecular changes in the chemical bonds of the reactant, 
solid solution formation and final separation of the product. The most common solid state 
reactions of the drug substances include the deamidation, hydrolysis, cyclization and 
oxidation. The reactions of the active substance with the excipients of the formulation have 
influence on the stability of the product. Mechanical stress during the compaction process is 
one of the factors which can have impact on the solid state reactions as creating surface 
area, increasing the number of defects and the presence of amorphous material in the result 
of compaction of the tablet could accelerate the interactions [151, 153]. 
 
In this chapter the solid tablets compacted from the binary formulation are analyzed and the 
possible interaction within the samples are discussed.  
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4.1 Aims: 
 To manufacture the reproducible tablets in situ on the ATR crystal from binary 
formulations and investigate possible interactions of the components of the mixtures 
 To build a PLS model and predict the concentration values for the excipients of 
analyzed formulation 
 To conduct the analysis of the components distribution in the tablets   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
4.2 Materials and methods: 
4.2.1 Materials 
Materials used in this chapter are listed in Chapter 2, Table 2.1  
4.2.2 Preparation of the mixtures  
Formulations were prepared according to proposed concentration values (Table 4-1).  
Formulation of: 
                           HPMC and citric acid            HPMC and active substance 
HPMC [%] Citric acid [%] HPMC [%] Active substance 
[%] 
95 
90 
80 
50 
5 
10 
20 
50 
90 
80 
70 
60 
50 
10 
20 
30 
40 
50 
                
Table 4-1. Concentrations of binary formulations 
 
The binary formulations were prepared by the method described in Section 3.2.2.2.  
The active substance was ground and passed through the sieve (the size of the sieve <106 
microns) to match the particle size of other excipients. The formulations were tumble 
blended for 15min. 
 
4.2.3 Compaction process 
The compression of the tablets followed the procedure described in Section 3.2.4.2 and the 
parameters for the mixtures with particle size less than 106 microns detailed in Section 
3.2.4.3 
 
 
 99 
 
4.2.4 PLS analysis 
The predicted values of excipients concentration of the formulations were obtained as a 
result of the data analysis described in Section 3.2.5. 
 
4.2.5 NIR Imaging  
Distribution of the components and image data analysis was conducted according to 
parameters listed in Section 3.2.6. 
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4.3 Results and discussion 
4.3.1 Investigations of possible interactions of the powders in the compacted tablet  
Various structural features in the samples may be revealed by the analysis of infrared 
spectra which provides information on a molecular level. The absorption bands of a 
particular group may be shifted by possible interactions between excipients. Conjugation, 
van der Waals forces, hydrogen bonding or electron withdrawal by a neighbouring 
substituent are few examples of interactions which one could recognize in the spectrum of 
analyzed mixtures [69, 70, 154].  
 
In this study the spectra from tablets were analyzed in order to confirm if any solid state 
interactions between the substances took place during the mixing and compaction process.  
 
4.3.1.1 Formulation: HPMC and citric acid 
 
Spectra from the formulation HPMC citric acid (Fig 4-1) showed the strong characteristic 
band ~1100 cm
-1
 ν(CO) associated with the presence of HPMC in the samples along with 
with the increasing concentration of the citric acid. The shape of the bands change 
proportionally to the increasing amount of citric acid in the sample however the peak 
positions remained the same. In the region ~3570-3200 cm
-1
 ν(OH) the overlapping bands 
associated with the presence of hydroxyl groups in the polymer and citric acid result in a 
wide band. The shape is contributed to the presence of ν(OH)  band associated with citric 
acid where non hydrogen bonded hydroxyl groups forms a narrow sub-maximum peak 
~3500 cm
-1
 as well as OH bonded stretching absorption at lower wavenumber within the 
discussed region. The secondary absorption for ν(OH) near the ~2600 cm-1 region is 
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observed as the effect of overlap of the CH stretching region. Increasing intensity of the 
citric acid bands proportionally to its concentration in the formulation is also observed in 
mixtures spectra between ~1750-1680 cm
-1
 associated with the characteristic carbonyl 
group (C=O) stretching frequency, and with presence of ~1175-1045 cm
-1
 strong absorption 
ν(CO) and ~955-890 cm-1 region associated with OH deformation vibration of carboxyl 
group. However the solid mixtures spectra have no indication of bands shifts which could 
suggest any solid state interactions between the ingredients of the sample [31, 32].  
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Formulation of HPMC and Citric acid 
a) 
 
b) 
 
Fig 4-1. Infrared spectra of: pure HPMC, the mixtures of HPMC and citric acid with 
proposed concentrations and pure citric acid, a) region 3700-2400 cm 
-1 
, b) region 1900-
700 cm 
-1
.  
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4.3.1.2 Formulation HPMC and active substance 
 
Spectra collected from formulations of HPMC and active substance (Fig 4-2) showed 
increasing impact of active substance in the mixture spectrum proportional to increasing 
concentration of API in the mixtures. The spectra of the formulations showed a relatively 
strong absorbance band in the region 1700-1650cm
-1
 which is associated with the C=O 
stretching mode and  C=C skeletal benzene ring breathing modes in the region 1600-
1500cm
-1
, which increased in intensity with the amount of active substance in the mixture. 
In the range 3500-3100 cm 
-1
 , the OH stretching band is associated with the presence of 
hydroxyl groups in HPMC as well as 6OH BP. The strong band in the region ~1100 cm
-1 
is 
associated with the CO stretch of the HPMC [49, 50].  
 
The prepared mixtures spectra showed the presence of overlapping peaks at certain 
wavenumbers however there are no shifts in the positions of the bands which suggest that 
during the admixing of powders and compaction process no chemical interactions between 
the excipients took place.  
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a) 
 
b) 
 
 
Fig. 4-2 Infrared spectra of: pure HPMC, mixtures of HPMC and API, pure active 
substance a) spectral region 3700-2400 cm 
-1
, b) region 1900-700 cm 
-1
.  
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4.3.2 Prediction of the concentration values of the formulation ingredients 
The concentration values of the excipients in the analyzed tablets were predicted using PLS 
data analysis on the previously collected sample spectra from binary formulations [94]. 
 
4.3.2.1 Mixtures of HPMC and citric acid 
The samples selected for PLS data analysis were divided into two sets: the calibration set 
which consisted of 12 samples and the prediction set which consisted of 8 samples. 
Preprocessing of all the data was conducted and included path length correction and mean- 
centering. 
Formulation HPMC and Citric acid 
 
Fig 4-3 Output of the PLS analysis showing the predicted versus calculated values for 
various binary mixtures of formulation HPMC and citric acid. 
Mean and standard deviation for two components used in blended samples 
concentration of citric [%] mean citric [%] concentration of HPMC [%] mean HPMC [%] st dev. 
50 48.48 50 51.52 2.55 
20 21.21 80 78.79 2.73 
10 8.67 90 91.33 1.91 
5 5.26 95 94.73 2.34 
Table 4-2 Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the samples. 
The plots (Fig 4-3), show the predicted versus the actual concentrations from the PLS data 
analysis. The data fitted into the PLS linear model obtaining values of R
2
 coefficient around 
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0.9814. The collected spectra from samples of the same formulation show some variability 
in the intensity values for some bands, these differences in the data as well as possible 
measurement error will influence the final R
2
 coefficient value.  
The predicted concentration values show a high level of similarity when compared to the 
actual concentrations values. The calculated mean and standard deviation values for both 
components and the independent sample which fitted into the model confirmed the high 
level of reproducibility of the analyzed samples.  
In the next step of the PLS analysis, the predicted spectra of pure components were 
compared with the IR spectra collected from pure standard substances (Fig 4-4).  
 
 
Fig. 4-4 Predicted pure component spectra from PLS analysis compared with the IR spectra 
of pure substances: red colour -IR spectra, blue colour-the predicted PLS spectra. 
The presence of any noise and the wide variety of the bands intensity according to used 
concentrations will affect the final intensity of the estimated spectra. Analyzing the position 
and shape of the particular bands, characteristic for the substances with full confidence one 
could recognize and justify the presence of citric acid spectrum and HPMC. There are no 
band shifts present in the predicted spectra. 
Also the principal components spectra (Fig 4-5) indicated the presence of characteristic 
bands for citric acid (principal component1) and for HPMC (principal component2). 
Citric  ac id PLS predic tion
Citric  ac id IR spectrum
 0.00
 0.05
 0.10
 0.15
 0.20
 0.25
 0.30
 0.35
 0.40
 0.45
 0.50
 0.55
 0.60
 0.65
 0.70
 0.75
 0.80
 0.85
 0.90
L
o
g
(1
/R
)
 1000   1500   2000   2500   3000   3500  
Wavenumbers (cm-1)
HPMC PLS prediction
HPMC IR spectrum
-0.0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0.7
 0.8
 0.9
 1.0
L
o
g
(1
/R
)
 1000   1500   2000   2500   3000   3500  
Wavenumbers (cm-1)
Citric acid HPMC 
 107 
Principal components (eingenvectors) represent the changes in spectral data common to all 
calibration spectra. Multiplying the PC1 &PC2 by the set of scores and summing the results 
with the mean spectrum one should be able to recreate the calibration data set.   
  
Fig 4-5 Principal components predicted by the PLS analysis HPMC and citric acid 
formulation.  
The press plot (Fig 4-6) indicates that 2 factors are required to describe the variance in this 
data set. Therefore this number was used for the PLS analysis. 
 
Fig 4-6 Press plots showing the number of factors required for the PLS analysis of the citric 
acid and HPMC formulations. 
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The RMSECV values calculated for both substances showed high level of similarity, 
consequently the press plots for the analyzed substances indicated the same amount of 
factors [155, 156].   
 
4.3.2.2 Mixtures of HPMC and active substance 
The samples selected for PLS data analysis for this formulation included 30 sample spectra 
from 5 formulations, 6 spectra each; plus independent sample spectra. The data set was 
divided into two groups: calibration set 19 samples and prediction set 11 samples.  
Formulation HPMC and active substance 
 
Fig 4-7 Output of the PLS analysis showing the predicted versus calculated values for 
various binary mixtures of formulation HPMC and active substance. 
 
Mean and standard deviation for two components used in blended samples 
Concentration of HPMC [%] mean HPMC [%] Concentration of active [%] mean active [%] st dev 
50 54.97 50 45.02 5.49 
60 62.79 40 37.20 4.83 
70 73.16 30 26.83 3.41 
80 72.04 20 27.95 4.02 
90 88.43 10 11.57 3.07 
Table 4-3 Comparison of the mean and standard deviation calculated concentration with the actual 
concentration for the samples. 
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The data generated from formulation HPMC and active substance (Fig. 4-7) are showing 
the predicted concentration versus the actual one, using stated calibration samples and 
validation set. The values obtained for HPMC and active substance fitted into the model 
with visible variability. The obtained values of R
2
 coefficient are <0.9 which is connected 
with the variance between the collected data values. The mean and standard deviation 
values (Table 4-4) are confirming slightly bigger variability between analyzed samples than 
in case of formulation HPMC and citric acid.   
The results suggest higher level of heterogeneity of the tablets in the formulation HPMC 
and API compared with the mixtures made from citric acid and HPMC. The active 
substance showed different compressibility properties than citric acid, also one could 
assume the segregation process occurring within the tablet based on lower level of 
reproducibility of the analyzed samples.  
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The PLS predicted spectra of pure components compared with the IR spectra collected 
from pure standard substances (Fig 4-8) indicated the presence of active substance 
characteristic bands and the HPMC strong absorption band ~1100 cm
-1
 associated with 
υ(CO). The negative peak associated with the presence of HPMC in the active substance 
spectrum was observed, as well as the pure component spectrum (HPMC) contains the 
bands associated with the active substance, suggesting that the PLS method could not 
exactly predict the pure components for this data set 
 
 
Fig 4-8 Comparison of IR spectra of pure substances (red colour) with the predicted pure 
components spectra (blue colour). 
 
The principal components analysis (Fig 4-9) showed presence of three principal 
components (PC’s). The PC1 and PC2 contain a mixture of bands characteristic for both 
substances, although PC2 shows the significantly increased intensity of the bands 
associated with the presence of HPMC and few negative peaks of active substance. PC3 
spectrum is a negative spectrum of the pure API.  
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Fig 4-9 Principal components spectra generated in the PLS analysis of the formulation 
HPMC and active substance.  
 
The press plots (Fig 4-10) generated for both components of the formulation showed the 
calculation of the factor numbers. The software application suggested using the one factor.  
 
Fig. 4-10 Press plots showing the number of factors required for the PLS analysis of the 
active substance and HPMC formulations. 
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In order to avoid under-fitting of the model 2 factors were used for the analysis. The values 
of RMSECV showed similar amounts for both substances. Changing the number of factors 
didn’t bring an improvement in this data analysis [150, 157, 158].  
 
4.3.3 Distribution of the components in a binary formulation tablets 
The most significant factor determining the quality of the formulated product is the 
structure of the matrix. It is critical to eliminate any potential manufacturing defects which 
may influence the solid dosage form and its release. The content uniformity; 
homogeneously distributed components in the product are one of the most desirable 
achievements in the early stage of method development [88, 159]. 
The distribution of components in the binary formulations was analyzed in order to 
compare the effect of admixing citric acid or active substance separately into the polymer 
matrix. 
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4.3.3.1 Formulation: HPMC and citric acid 
Results showing the set of six images top and bottom side collected from manufactured 
tablets using powders predominantly blended. 
 
  
 
 
 
 
 
 
Fig 4-11a. NIR images bottom side of the tablets prepared by blending binary mixture 
HC50/50 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
Fig 4-11b. NIR images top side of the tablets prepared by blending binary mixture 
HC50/50 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-11c. NIR images bottom side of the tablets prepared by blending binary mixture 
HC80/20 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
Fig 4-11d. NIR images top side of the tablets prepared by blending binary mixture 
HC80/20 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
80%HPMC and 20% citric bottom 
Citric acid Distribution                                 HPMC Distribution 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
Pixels
P
ix
e
ls
50 100 150 200 250 300
50
100
150
200
250
0.2
0.4
0.6
0.8
Pixels
P
ix
e
ls
50 100 150 200 250 300
50
100
150
200
250
80%HPMC and 20% citric top 
Citric acid Distribution                                 HPMC Distribution 
 
 
 
0
0.05
0.1
0.15
0.2
0.25
Pixels
P
ix
e
ls
50 100 150 200 250 300
50
100
150
200
250
0.2
0.4
0.6
0.8
1
Pixels
P
ix
e
ls
50 100 150 200 250 300
50
100
150
200
250
 115 
 
 
 
 
 
 
 
 
Fig 4-11e. NIR images bottom side of the tablets prepared by blending binary mixture 
HC90/10 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
 
Fig 4-11f. NIR images top side of the tablets prepared by blending binary mixture HC90/10 
of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-11g. NIR images bottom side of the tablets prepared by blending binary mixture 
HC95/5 of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
Fig 4-11h. NIR images top side of the tablets prepared by blending binary mixture HC95/5 
of citric acid and HPMC using torque 90 [cN.m] applied pressure. 
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The generated NIR images of the formulations of HPMC and Citric acid (Fig 4-11a-h) 
showed the distribution of the two excipients present in the analyzed tablets. These 
chemical maps of the samples provided information about the level of intensity of the 
particular component on the tablet surface. The red colour is associated with strong 
intensity value and therefore high concentrations of the component, whilst dark blue colour 
is an indication of low concentration of the substance in the particular region of the sample. 
There is a significant difference in the intensity observed between the samples images 
collected from the top and bottom side of the tablet. The tablet images from the top surface 
show a more uniform distribution within components of the tablet. There are no aggregates 
visible or any clusters visible although they can still be found on the images of the bottom 
side (Fig4-11g-h). Also the tablets from the top side images have recognizable regular 
shape whilst the bottom side of the tablet is deformed by the relaxation of the polymer 
during the tablet manufacturing process.  The further analysis of the samples with different 
concentrations shows the general trend of segregation of the compacted powders within the 
tablet. The increasing concentration of HPMC - red colour on the chemical map is mainly 
observed on the top side of the tablets whilst on the bottom side the presence of both 
components is visible.  Also the roughness of the sample surface has an influence on the 
quality of the generated images, as smoother surface of the sample from the top side of the 
tablet improves the quality image compared to the bottom part. The presence of blue circles 
around the edges of the tablets is associated with the lack of integrity of the tablet at the 
edge. 
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Although the distribution and uniformity of the citric acid and HPMC compared with 
previously discussed results (Chapter 3) is significantly improved through the modification 
of particle size and blending time, there are still visible differences within a set of 6 tablets 
from the same concentration of the components. The HPMC is heterogeneous with respect 
to its particle size and therefore more challenging in terms of obtaining appropriate sized 
particles. The possible improvement of the mixture preparation could be obtained by first 
granulation of the excipients, then blending the mixture followed by compaction of 
samples.   
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4.3.3.2 Formulation active substance and HPMC 
Results showing the set of six images top and bottom side collected from manufactured 
tablets using powders predominantly blended. 
 
 
 
 
 
 
 
 
Fig 4-12a. NIR images bottom side of the tablets prepared by blending binary mixture 
HA50/50 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
Fig 4-12b. NIR images top side of the tablets prepared by blending binary mixture 
HA50/50 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-12c. NIR images bottom side of the tablets prepared by blending binary mixture 
HA60/40 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
Fig 4-12d. NIR images top side of the tablets prepared by blending binary mixture 
HA60/40 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-12e. NIR images bottom side of the tablets prepared by blending binary mixture 
HA70/30 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
   
 
Fig 4-12f. NIR images top side of the tablets prepared by blending binary mixture HA70/30 
of active substance and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-12g. NIR images bottom side of the tablets prepared by blending binary mixture 
HA80/20 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
 
Fig 4-12h. NIR images top side of the tablets prepared by blending binary mixture 
HA80/20 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
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Fig 4-12i. NIR images bottom side of the tablets prepared by blending binary mixture 
HA90/10 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
 
 
 
 
 
 
 
 
 
Fig 4-12j. NIR images bottom side of the tablets prepared by blending binary mixture 
HA90/10 of active substance and HPMC using torque 90 [cN.m] applied pressure. 
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The analysis of the NIR images (Fig 4-12a-j) from the top and bottom sides clearly 
indicated an increased regularity of distributed components on the top of the tablet together 
with higher intensity values. The images from the top samples indicated possible 
segregation of the components within the tablet since more of the active substance particles 
seemed to be present on the top side than the bottom side and also showed higher intensity 
values. In addition the general distribution of API within each set of six tablets was more 
uniform on the top rather than on the bottom side. However it is known that active 
substances tend to be distributed in the form of clumps or small particles rather than be 
evenly dispersed, this could be observed in the bottom NIR images from the samples 
showing the drug distribution [159, 160].  
In the case of HPMC chemical maps a more uniform distribution of particles were  
observed on the top side of the tablet however the intensities obtained for the top and 
bottom sides of the tablet were similar. There was definitely more variety observed for the 
bottom sides within the set of six tablets for each concentration. Each set shows the 
selection of six tablets with the range of high level absorption (dark red colour) to the very 
low values of the intensity (blue colour) on the surface. The differences between the tablets 
within one set of respective concentrations could be explained by the fact that HPMC itself 
is a heterogeneous substance (i.e. with respect to particle size). Although the optimization 
of the mixing conditions of the formulation improved the distribution of the HPMC within 
the tablet, as almost no more clusters or aggregates were found in the samples, this 
component still showed more heterogeneous distribution on the tablet surface than the 
active substance. Also the irregular shape of the tablets images bottom side is connected 
with the stress relaxation of the HPMC after the tablet manufacturing process, which also 
has an influence on the analyzed results. Finally the image of the sample 80% HPMC and 
20% of active substance bottom side (Fig 4-12g) shows clearly the impact of mechanical 
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defect occurred after manufacturing process [159, 161, 162]. The dark blue region on the 
images of both components shows the lack of substances in that particular place. As the 
compressed tablets in-situ on the ATR crystal used to sometimes stick to the crystal, the 
spatula was required in order to remove them. The blue region is caused by the necessity of 
using spatula which generated the changes on the surface removing the outer layer of the 
powder from the bottom side of the tablet.  
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4.4 Conclusions 
The analysis of solid dosage forms from binary systems provided information about the 
chemical and physical properties of the mixed and compressed formulations. The FTIR 
analysis of the prepared mixtures showed the presence of the characteristic bands for the 
analysed substances however no changes in the position of the bands where observed 
indicating there was no hydrogen bonding between the mixed excipients in the analyzed 
spectra. The peaks of the mixed substances overlapped with each other indicating the 
necessity of using more advanced methods of data analysis in order to adequately analyze 
the data which will be generated in the presence of dissolution media.  
The conducted PLS data analysis confirmed a good level of reproducibility of the samples 
in case of HPMC and citric acid formulations, which were also compatible with the 
chemical imaging data. However in case of HPMC and API formulation the results 
obtained from PLS showed higher levels of variance of the HPMC component in the 
tablets. Chemical maps of the HPMC distribution confirmed the more heterogeneous 
surface for this component in comparison with API distribution.  
Also the analysis of the images of the top side of the tablets showed the general tendency of 
API to segregate on that part of the tablet as all analyzed samples indicated higher intensity 
for the API particles than on the bottom side. Both substances presented more uniform 
distributed particles on the top side of the tablet than on the bottom.  
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5. Investigations of binary formulations in a 
dissolution media. 
Drug dissolution involves many interactions in formulations with drug substances including 
chemical reactions, hydration of the sample, protonation/deprotonation, the emergence of 
new species, hydrogen bonding and solvation. Particular interest is usually directed at the 
drug-substance which can react with other excipients of the formulation during its release 
from the polymer matrix. The main aim of investigating controlled drug release is to 
prevent possible unnecessary reactions of the active substance in the dissolution media and 
also improving and modifying the drug release behaviour so the final mechanism of the 
formulation will be understood.  
In the first step any new possible chemical species or molecular changes in the chemical 
bonds of the reactants should be monitored, to provide information about the properties of 
the investigated formulation. Standard dissolution testing provides the percentage of the 
dissolved drug released over a specified duration of time. However, this technique is not 
able to provide any information  about the formulation at the molecular level [151, 153]. 
 
In this chapter the solid tablets compacted on the diamond ATR were introduced to the 
dissolution media, possible molecular interactions in the experiments are a subject of 
discussion. 
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5.1 Aims: 
 To investigate drug release from binary formulation in different media  
 To conduct the analysis of interactions of the components in an aqueous 
environment     
 To monitor the hydration and hyphenation experiments and develop information 
about the formulation behaviour in static and dynamic conditions 
 To validate MCR as a tool to study such systems 
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5.2 Materials and methods: 
5.2.1 Materials 
Materials used in this chapter are listed in Chapter2, Table 2.1 
5.2.2 The analyzed formulation  
Formulation of: 
                           HPMC and citric acid            HPMC and active substance  
HPMC [%] Citric acid [%] HPMC [%] Active 
substance [%] 
95 
90 
80 
50 
5 
10 
20 
50 
90 
80 
70 
60 
50 
10 
20 
30 
40 
50 
    Table 5-1. Concentrations of binary formulations 
The binary formulations were prepared by the method described in Section 3.2.2.2.  
The active substance was passed through a sieve to match the particle size of API with the 
other excipients.  
 
5.2.3 Dissolution testing 
The experiments were carried out for 12 h at 37.0 ± 0.5 
o
 C, basket rotational speed was 
100 rpm ± 4 rpm and during the last 30 min an infinite spin was used which increased 
speed of basket rotation to 200 rpm. The types of media used were distilled water, 0.1N 
HCL, pH 6.8 phosphate buffer. The volume of medium was 1000 ml ± 10 ml. For 
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dissolution testing the USP apparatus I (baskets); QE Distek bath DT1/UV20 and PD 
Distek bath PT13/UV19 were used. The spectrophotometer Agilent 8453 UV automated 
dissolution system was set with a wavelength of 238 nm for distilled water and phosphate 
buffer and 234nm for 0.1N HCl. The wavelength appropriate for the active substance in 
different media was chosen based on the UV response for the standard solutions (API 
dissolved in the media) as shown at the Fig 5-2. 
a) 
 
b) 
 
Fig 5-2 The example of UV spectra showing the wavelength values for two standards made 
from the active substance dissolved in 0.1 N HCl (a) and API dissolved in distilled water 
(b).  
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The total weight of the tablet tested was 200 mg. The tablets were compacted using the 
Stylcam 100R compression simulator with the compression force 850-950 daN. The choice 
of compression force used was based on the comparison between different forces and 
measured thickness, weight of the sample and hardness of the tested tablets from two 
chosen formulations. 
 
 
Fig5-3. Hardness of tested tablets against compression force. Each data point represents the 
average value of three tablets. 
The hardness of the tablets was tested using a Schleuniger Pharmatron Tablet Hardness 
Tester, model 6D. Preferable hardness for tablets with weight of 200 mg is between 9-10 
Scu* [163]. 
*1 Scu = 7N  
* 1 N = 0.1 daN 
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5.2.4 Preparation of the solutions 
The HPMC, API and Citric acid solutions were prepared independently and FTIR spectra 
were collected with the spectral parameters described in a chapter 3, section 3.2.4.2. 
5.2.4.1 Preparation of the HPMC solutions 
The required weight of polymer was mixed with water in a mortar and pestle. When the 
powder appeared evenly distributed in the water, the solution was transferred to a sealed 
glass container. The solutions were stored at 4 
o
C for one week to allow the polymer to 
fully hydrate. Eleven solutions were prepared using 10 ml of water and the required 
polymer weight to obtain aqueous solutions in the range from the 45%-95% (every 5%).   
5.2.4.2 Preparation of API solutions 
The active substance is freely soluble in water so the solutions were prepared by 
incorporating the required weight of API powder to the appropriate mass of water. The 
percentage of prepared solutions w/v was 1%, 2%, 5% and 10% in 10 ml of distilled water.  
The solutions of API exceeding 10% were saturated such that the active substance powder 
was visible in the solution. 
5.2.4.3 Preparation of Citric acid solutions 
The citric acid solutions were prepared by incorporating the required weight of the acid 
powder to the appropriate mass of water. The percentage of prepared solutions was 5%, 
10%, 15%, 20% and 50% in 10 ml of distilled water.  
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5.2.5 Hydration and Hyphenation experiments 
Static hydration experiments were conducted in situ on the diamond ATR. The dissolution 
media was introduced through the channels of the compaction cell to the compacted tablet. 
The experiment was monitored for a duration of 12 h, and the spectra were recorded every 
3 mins. The parameters for spectral collection were kept the same as those used for the 
solid dosage form.  
The hyphenation experiments were conducted by coupling the compaction cell on the 
FTIR-ATR equipment to a UV detector and HPLC pump to make a closed circulation 
system for dissolution media. The HPLC pump was connected to the compaction cell with 
PE tubing, the dissolution media with a flow rate of ~0.5 ml/min was introduced to the 
compacted sample; the temperature was set to 37 oC on the ATR crystal.  
The outlet from the compaction unit was directed to the UV detector were the signal from 
the sample was measured. The liquid from the UV detector was directed back into the 
reservoir beaker, and the total volume of the dissolution media was 450 ml. The liquid in 
the beaker was constantly mixed throughout the duration of the experiment, and pumped 
through the compaction cell. Values measured from the UV detector were recorded by the 
voltagemeter Ut60a software. 
A calibration of the UV absorbance was made using different concentrations of active 
substance in water and the output was recorded, using the wavelength of 238 nm. The data 
is shown in Fig 5-4.  
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Fig. 5-4 Output of the signal from voltagemeter connected to the UV detector using active 
substance dissolved in distilled water 
API is a freely soluble in water substance. Based on the values obtained during the 
calibration experiment the UV output from the mixtures of different formulations will be 
analyzed for the appropriate values of API in the samples. 
5.2.5.1 Preparation of the dissolution media 
6.8 pH phosphate buffer  
Sodium hydroxide (0.83g) and potassium dihydrogen orthophosphate (6.48g) were 
dissolved in 1 liter of distilled water.  
0.1n HCl solution 
1 liter solution: 100 ml of concentrated HCl was added to distilled water 900 ml. 
The pH of the prepared dissolution media was measured by a PHM220 pH Meter 
657R056NO11. 
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5.2.6 MCR data analysis  
The MCR analysis was conducted using the three different applications (Tauler, Hancewicz 
and PLS toolbox) to allow an independent comparison of the calculated results [164, 165].  
The predicted number of components for binary system was set as 5 considering the 
number of components i.e. pure active substance, pure HPMC, medium, hydrated API and 
hydrated HPMC. Apart from pure substances one would assume the presence of the 
hydrated species in the samples. ALS optimization was used to optimize the MCR results. 
The MCR-ALS method is very flexible and applicable to many samples. [94]. 
 
 
 
 
 
 
 
 
 
 136 
5.3 Results and discussion 
5.3.1 Effect of pH dissolution media on the drug release from binary formulation. 
Despite the solubility of the active substance, drug/polymer load in the formulation and 
manufacturing conditions (for example compression force, hardness of the tablet), the drug 
release is also influenced by the surrounding conditions for example pH of dissolution 
media especially when the drug has pH dependent solubility [27, 30]. 
The dissolution experiments for HPMC and active substance formulation were conducted 
in distilled water, pH 6.8 phosphate buffer and 0.1 N HCl; pH 1.5. 
 
5.3.1.1 Dissolution of the binary formulation in distilled water using gelatin capsules. 
The appropriate amount of powder of formulations HPMC and active substance was placed 
in the gelatine capsules and the dissolution testing was conducted. The possible interference 
coming from gelatine capsule was removed from the obtained results by running the 
dissolution analysis of the empty capsule in the dissolution vessel and extracting the 
capsule values from the formulation results. 
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Fig 5-3 Mean dissolution profiles for formulations of HPMC and active substance. The 300 
mg gelatin capsules were dissolved in distilled water. 
The dissolution profiles of the binary formulation (Fig 5-3) obtained from the experiment in 
distilled water as a medium, showed variability between 97-100 % drug release values over 
the course of the experiment. Also the curve of the obtained profiles suggests that the drug 
from the capsule is released gradually during the test and dissolution rate is determined in 
such a case by dissolution and diffusion process [130]. Alternatively one would expect 
sudden changes in dissolution drug percentage resulting from the tablet erosion. 
  
Fig. 5-4 Dissolution rates, mean concentration profiles of active substance versus time. 
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The concentration versus time profiles (Fig 5-4) for active substance showed very similar 
dissolution rates for all analyzed concentrations of the formulations. The rate of release for 
90% HPMC and 10% of active substance formulation is reduced in comparison with 50% 
of HPMC and API in the mixture [166].  
According to Ford et al (1985) the most important factor affecting the drug release from  
HPMC matrices is the drug/HPMC ratio as the increased polymer concentration causes an 
increase of the viscosity of the gel layer and as a consequence the longer diffusional paths  
decrease drug release rates [26, 27].  
 
5.3.1.2 Dissolution testing of the tablets from binary formulations in pH 6.8 and 0.1N HCl. 
 
Fig 5-5 Mean dissolution profiles for formulations of HPMC and active substance, the 200 
mg tablets were placed in pH 6.8 phosphate buffer or 0.1N HCl as the dissolution media. 
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The dissolution profiles of binary mixtures (Fig 5-5) showed a significant difference 
between the samples tested in pH 6.8 and 0.1N HCl. Quicker release and higher 
percentages of dissolved active substance was observed in case of 0.1N HCl medium as 
expected. The profiles of dissolved tablets in the same medium obtained similar values of 
released drug over time independently from the amount of active assayed in tested 
formulations.  
 
Fig 5-6 Dissolution profiles for HPMC and active substance formulation within pH 6.8 
phosphate buffer and 0.1 N HCl as a dissolution media. 
The concentration profiles analysis confirmed the higher amount of released drug in shorter 
time in the case of samples tested in 0.1 N HCl compared to those in the pH 6.8 media. The 
binary mixtures tested in different pH’s had a larger variability of the final percentage 
dissolved drug of 84% (samples tested in pH 6.8 medium) to 97% for samples tested in 
0.1N HCl. Such a difference can be visually confirmed by the amounts of remaining 
residues of active substance in the HPMC gel after the 12 h dissolution experiment finished 
Concentration profile of the drug dissolved in 
0.1N HCl and pH 6.8
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
0 200 400 600 800
Time (mins)
6-
O
H
 B
u
sp
ir
o
n
e 
H
yd
ro
ch
lo
ri
d
e 
p
la
sm
a 
co
n
ce
n
tr
at
io
n
 (m
g
/m
l)
60% HPMC 40%
active 0.1N HCl
60% HPMC 40%
active pH 6.8 
80% HPMC 20%
active in 0.1N HCl
80% HPMC 20%
active pH 6.8 
 140 
(Fig 5-7, 5-8). Also it is a clear indication of the pH dependence of the tested system as one 
would expect. 
a)                                                            b) 
 
Fig. 5-7.a) 80% HPMC 20% active, tablets after 12h experiment in pH 6.8. Powder 
particles are visible in a gel matrix b) 80% HPMC 20% active gel after 12h experiment in 
0.1 N HCl.  
          a)                                                  b) 
 
Fig. 5-8.a) 60% HPMC 40% active substance, tablets after 12h experiment in pH 6.8. Still 
visible dispersed little particles of powder around the gel, b) 60% HPMC 40% active gel 
after 12h experiment in 0.1N HCl. Visible presence of air bubbles in a matrix. 
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The presence of high numbers of air bubbles in the gel (Fig 5-7b, 5-8b) confirm the high 
percentage of the drug release from the polymer matrix in 0.1 N HCl during the 12h 
experiment compared to the pH 6.8 media which gave slower release and lower percentage 
released values for dissolved drug.  
The results from pH 6.8 and distilled water showed similar dissolution rates. 
5.3.2 Investigations of possible interactions of the binary formulation in the hydrated state 
The analysis of the infrared spectra of hydrated samples provides information on a 
molecular level which is not possible to obtain directly from standard dissolution testing 
methods. The absorption bands of the characteristic groups may reveal the possible 
interactions between the excipients of the formulation and the dissolution medium. Also the 
presence of any new products in the sample could be justified as a result of the chemical 
interactions like protonation/deprotonation processes, van der Waals force or hydrogen 
bonding effecting the bands position in the spectra  [69, 70, 154].  
In this study the hydrated tablets spectra were analyzed in order to confirm the presence of 
possible interactions between the substances. 
5.3.2.1 Aqueous solutions of exipients 
Aqueous solutions of HPMC, active substance and citric acid were prepared independently 
and their spectra were collected using FTIR-ATR instrument as described previously in the 
Chapter 3.  
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b) 
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c) 
 
Fig  5-13. a)Spectra of different HPMC concentrations as aqueous solutions, b) Spectra of 
same HPMC aqueous solutions region in 1900-700 cm 
-1 
, c) Comparison of HPMC 
solutions spectra with solid polymer and water spectra. 
Increasing concentration of HPMC has significant impact on the changes in the intensity of 
the bands between 1000-1200 cm
-1
 (ν C-O), and 2800-3000 cm-1 (ν (CH)). Comparing the 
spectrum of solid HPMC with solutions spectra, the complex band 1250-950 cm
-1
 is wider 
than in the solutions spectra. These changes are a result of polymer hydration process with 
the dominance of inter-molecular H bonding over the intra-molecular H-bonding [167].  
 The change in the shape of the ν(OH) band and its shift to the wavenumber 3600-3000 cm-
1
 ν(OH) was observed as well. It is the indication of weakening of the water H-bond 
network as the effect of inclusion HPMC in water solution. Also the visible shift to the 
higher wavenumber suggests the presence of the component referred to as weakly hydrogen 
bonded water.  The OH bending mode of liquid water is less sensitive to changes in the 
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hydrogen bonded network decreases in the intensity with the increasing polymer 
concentration, as one would expect.  
Aqueous solutions of Citric acid 
a) 
b) 
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Citric  ac id 10% 37C Tue Jan 22 11:56:54 2008 (GMT+00:00)
Citric  ac id 5% 37C Tue Jan 22 12:05:53 2008 (GMT+00:00)
Citric  ac id 50 % 37 C Tue Jan 22 12:48:49 2008 (GMT+00:00)
Citric  ac id 15%  37C Tue Jan 22 12:07:04 2008 (GMT+00:00)
Citric  ac id 20 %  37C Tue Jan 22 12:23:26 2008 (GMT+00:00)
citric acid plain dry 100 mg f90 106 microns 1 Thu Nov 23 18:48:03 2006 (GMT+00:00)
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Fig 5-14 a).  Citric acid aqueous solution spectra, b) Citric acid solutions spectra in region 
1000-1400cm
-1
 and 1500-1700cm
-1
, c) Comparison of aqueous citric acid solutions spectra 
with solid substance spectrum 
Increasing concentration of citric acid in solutions has an influence on the intensity and 
shape of the bands in regions 1700-1500 cm
-1
 ν(C=O) and 1050-1400 cm-1 ν(C-O). The 
band at 3600-3000 cm
-1 ν(O-H) were significantly reduced in more concentrated solutions 
and the shape of the band had changed. The carbonyl band is sensitive to hydrogen 
bonding, so in the aqueous solution it forms broad peak. The changes in this area can be 
correlated with water concentration and deprotonation of the acid. This is verified in the 
region 1300 cm
-1
 with the appearance of the strong peak that could be assigned to the 
presence of the COO
-
 group. 
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Aqueous solutions of active substance 
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Fig 5-15. a) Active aqueous solutions spectra, b) Active substance spectra region 1500-
1700 cm 
-1 
c) Comparison of active aqueous solutions spectra with solid drug spectrum.
 
Increasing concentration of API in a solution results in the increasing intensity of peaks in 
the region 1600-1500 cm
-1
 due to ring vibrations and 1574-1541 cm
-1
 pyridine ring 
breathing modes. There is a reduction of intensity in the region 3600-3000 cm
-1
 ν(OH) 
caused by increasing concentrations of API in the solutions. There is also a slight change in 
the band shape. It is evidence of the presence of weakly hydrogen bonded water in the 
system. Comparing API spectrum with that in solution the bands between 2700-2400 cm
-1
 
due to delocalized N…H bonding (the interaction of nitrogen with HCl) as expected is not 
present in solution spectrum [74, 154, 168]. During the production process the pH of 6-
hydroksy buspirone solution is kept in the range pH 5-8 however there is no information 
published about the pKa value for this API. 
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5.3.2.2 Hydration experiments 
5.3.2.2.1 Formulation HPMC and active substance 
The results of hydration experiments will be discussed based on the example of 80% 
HPMC 20% Active substance mixture. 
 
Fig 5-16   Selection of few first sample spectra collected from formulation 80/20HA during 
12 h hydration experiment showing spectral changes from the solid mixture spectrum to the 
hydrated form (every 5 minutes). 
Results obtained from hydration experiment binary mixture of HPMC and active substance 
(Fig 5-16) showed increased intensity of the band ν(O-H) 3006-3699 cm-1 associated with 
water up take and decreased band ν(C-O) 980-1160 cm-1 as a result of the polymer swelling 
process. Spectra collected from formulation of HPMC and active substance showed 
increasing impact of dissolution media in the sample with time. The formulations spectra 
showed a decreasing relatively strong absorbance band in the region 1700-1650cm
-1
 
associated with C=O stretching mode and  C=C skeletal benzene ring breathing modes in 
the region 1600-1500cm
-1 
[49, 50]. Also the 2700-2400 cm
-1
 delocalized N…H bonding is 
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no longer presence in the hydrated sample. The increasing concentration of the dissolved 
active from the polymer matrix caused the reduction of the intensity of these bands. Also 
there are intense changes observed in the region 3600-3000 cm
-1
 associated with the ν(OH) 
of water due to hydration process.  
The obtained profiles shown in Fig 5-17 result from the integrated area of characteristic 
band representing each component: ~1100 cm
-1
 region ν(OH) for HPMC and the 
delocalized N....H complex band (region 2400-2700 cm
-1
) for the active substance. After 
specifying the right and left side of the integrated band and the baseline the software 
application carries out the subtraction. Although the integration operates only in a narrow 
spectral region, the subtraction removes the entire spectrum of the compound. 
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Fig 5-17. Profiles constructed from the characteristic integrated band areas of each 
component from the hydration experiment for the formulation 80% HPMC and 20% active 
substance; blue colour- water uptake, region 3600-3000 cm 
-1
 , red-HPMC region 1160-996 
cm 
-1
, pink-API region 2600-2400 cm 
-1
.   
 
In case of the active substance (Fig. 5-17) the profile decreased and achieved certain 
constant level. Dissolved active substance diffused out from the system matrix to the 
surrounding liquid reaching an equilibrium level. The initial increase of API and HPMC 
profile is associated with the presence of injected water which improves the contact 
between particles of the compressed powder with the ATR crystal. The rate of diffusion of 
the active substance over the whole experiment is faster than the relaxation time of the 
polymer indicating diffusion control. Linear profiles with reported in some cases induction 
time where sorption ratio is build gradually are quite characteristic for this particular 
category.  
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In order to obtain quantitative information the generated profiles were normalized and 
plotted against square root time. 
 
Fig 5-18. Normalized kinetic profiles of the hydrated sample formulation HA80/20 
There are different approaches which one could use in order to analyze and discuss the 
diffusion rates. There are several studies published discussing the rate of solvent diffusion 
in the polymers, however the thickness of the sample is a required parameter to determine 
the diffusion coefficient [83, 169]. In this project the studied system suffers from the lack 
of information about the thickness of the sample as the hydration or hyphenation 
experiments are requiring the tablet not to be removed from the ATR crystal after its 
compaction and the thickness of the tablet can not be calculated from the compaction cell 
dimensions. Considering the limitations of the conducted experiments the measurements of 
the slope value and x intercept was proposed. 
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Fig5-19. The Water uptake profile of the formulation HA80/20 
 
 
Fig5-20. The API profile of the formulation HA80/20 
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Fig. 5-21. The HPMC profile of the formulation HA80/20 
Profiles quantitative data 
HPMC Active substance Water uptake 
Slope Intercept
[s] 
R^2 Slope Intercept 
[s] 
R^2 Slope Intercept 
[s] 
R^2 
50% HPMC 50% active substance 
 
-0.0206 17015 0.994 -0.0144 13514 0.9951 0.0193 7437 0.9990 
60% HPMC 40% active substance 
 
-0.0196 13719 0.9946 -0.0217 11109 0.9962 0.0198 6882 0.9994 
70% HPMC 30% active substance 
 
-0.0178 26857 0.9962 -0.0263 16071 0.994 0.0171 6069 0.9992 
80%HPMC 20% active substance 
 
-0.0136 29317 0.9369 -0.0198 19791 0.9994 0.0168 6881 0.9971 
90% HPMC 10% active substance 
 
-0.0127 26802 0.9991 -0.0368 16538 0.9801 0.0138 5860 0.9974 
 
Table 5-2 The slope, intercept and R
2
 values for the analyzed binary formulation HPMC 
and active substance.  
 HPMC profile 
(formulation 80%HPMC 20%API)
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The analysis of the generated profiles for the binary formulation of HPMC and active 
substance (Fig 5-18-5-21) showed that with ingress of water into the tablet matrix the 
dissolved active substance diffuses out from the matrix faster whilst the polymer still 
continues the swelling process. The HPMC profiles showed the initial hydration of the 
polymer followed by the swelling process. There is a systematic change in the slope value 
for polymer which is increasing with the increasing concentration of HPMC in the sample. 
Water uptake slope values are decreasing with the increasing concentration of the HPMC in 
the sample, which confirms the suggested diffusion control process in the analyzed system. 
The API appears to be independent of concentration. 
5.3.2.2.2 Formulation HPMC and citric acid 
The results of hydration experiments will be discussed based on the example of 50% 
HPMC 50% citric acid mixture. 
 
Fig 5-37. Selection of few first sample spectra collected from formulation 50/50HC during 
12 h hydration experiment showing spectral changes from the solid mixture spectrum to the 
hydrated form (every 2 minutes). 
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.Results obtained from the hydration experiment with the binary mixture of HPMC and 
citric acid (Fig 5-37) showed increased intensity of the band ν(O-H) 3006-3699 cm-1 
associated with water up take and a decreased intensity band of the ν(C-O) 980-1160 cm-1 
as a result of the polymer swelling process. Spectra collected from this formulation showed 
an increasing impact of the dissolution media upon the sample with time. The citric acid in 
the sample showed changes in the intensity and shape of the decreasing bands in the 
regions 1700-1500 cm
-1
 ν(C=O) and 1050-1400 cm-1 ν(C-O). The carbonyl band is 
sensitive to hydrogen bonding ~1715 cm
-1
 , and there is evidence of the formation of the 
broad peak (~1375 cm
-1
 ) as result of citric acid reaction with dissolution media (eq5.1-5.3).   
Equilibrium equations for the citric acid in the aqueous solution  
C6H8O7 (aq) + H2O (l) <---> C6H7O7- (aq) + H3O+ (aq)         (eq 5.1) 
 
C6H7O7- (aq) + H2O (l) <---> C6H6O7
2-
 (aq) + H3O+ (aq)                          (eq.5.2) 
 
C6H6O7
2-
 (aq) + H2O (l) <---> C6H5O7
3-
 (aq) + H3O+ (aq)                                  (eq5.3) 
The changes in this area are correlated with water concentration and deprotonation of the 
acid.  
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Fig 5-38. The profile constructed from the characteristic integrated band areas of each 
components obtained from the formulation of HPMC and citric acid; dark blue colour- 
water uptake, region 3600-3000 cm 
-1
 , red-HPMC region 1160-996 cm 
-1
, blue-citric acid 
region ~950 cm 
-1
.   
 
Fig. 5-39 Normalized profiles for formulation HC80/20. 
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Fig. 5-40 Normalized profiles for water uptake. 
 
Fig. 5-41 Normalized profiles for citric acid. 
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Fig. 5-42 Normalized profiles for HPMC. 
Profiles quantitative data 
HPMC Citric acid Water uptake 
Slope Intercept R^2 Slope Intercept R^2 Slope Intercept R^2 
50% HPMC 50% citric acid 
-
0.0206 
7388 0.9914 -
0.0313 
5147 0.9966 0.0195 1532 0.9927 
80% HPMC 20% citric acid 
-
0.0144 
20023 0.9961 -
0.0178 
11580 0.9966 0.0168 4263 0.9966 
90%HPMC 10% citric acid 
-
0.0142 
26202 0.9963 -
0.0204 
18698 0.9965 0.0167 7683 0.992 
95% HPMC 5% citric acid 
-
0.0139 
26756 0.9923 -
0.0163 
19701 0.998 0.015 8542 0.9979 
Table 5-3 The slope, intercept and R
2
 values for the analyzed binary formulation HPMC 
and citric acid.  
 HPMC kinetic profile 
(formulation 80%HPMC 20%Citric acid)
y = -0.0144x + 2.0377
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Analysis of the generated profiles for the binary formulation of HPMC and citric acid (Fig. 
5-38 to 5-42) showed that citric acid dissolves and diffuses out from the polymer matrix 
whilst the HPMC still continues the swelling process. The HPMC profiles showed the 
initial hydration of the polymer followed by the swelling process. There is a systematic 
change in the slope value (Table 5-3)  for polymer which is increasing with the increasing 
concentration of HPMC in the sample as well as the water uptake profile showed 
decreasing slope values with increasing concentration of HPMC in the sample. The citric 
acid appears to be independent of concentration. 
The kinetic profile of citric acid decreases and achieves certain constant level. Dissolved 
acid diffused out from the system matrix to the surrounded liquid reaching an equilibrium 
level. The rate of diffusion of the acid is higher than the relaxation time of the polymer 
which suggests the diffusion control process.  
 
5.3.2.3. Hyphenation experiments of API and HPMC  
The hyphenation experiments are discussed based on the mixture 80% HPMC 20% active 
substance and 60% HPMC and 40% of active substance in 0.1 N HCl and pH 6.8 phosphate 
buffer as a dissolution media. 
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5.3.2.3.1 Hyphenation experiments in the pH 6.8 
 
Fig. 5-43. The normalized kinetic profiles of the hyphenated samples from formulation HA 
60/40 
 
Fig. 5-44. The normalized kinetic profile of water uptake formulation HA 60/40 
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Fig. 5-45. The normalized kinetic profile of active substance formulation HA 60/40 
 
Fig. 5-46. The normalized kinetic profile of HPMC formulation HA 60/40 
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5.3.2.3.2 Hyphenation experiments in the 0.1N HCl 
 
Fig. 5-47. The normalized kinetic profiles of formulation HA 80/20 
 
Fig. 5-48. The normalized kinetic profile of water uptake formulation HA 80/20 
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Fig. 5-49. The normalized kinetic profile of API formulation HA 80/20 
 
Fig. 5-50. The normalized kinetic profile of HPMC formulation HA 80/20 
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Kinetic profiles quantitative data 
HPMC API Water uptake 
Slope Intercept R^2 Slope Intercept R^2 Slope Intercept R^2 
60% HPMC 40% API in 0.1 n HCl 
-
0.0225 
14335 0.9995 -0.0187 8894 0.9904 0.0169 1408 0.9981 
80% HPMC 20% API in 0.1n HCl 
-
0.0237 
15575 0.9946 -0.0188 11679 0.997 0.0226 4506 0.9985 
60%HPMC 40% API in 6.8 pH 
-
0.0101 
24311 0.9927 -0.0215 13579 0.9928 0.0229 4635 0.9966 
80% HPMC 20% API in 6.8 pH 
-
0.0137 
18053 0.9841 -0.0183 12823 0.9779 0.0149 2771 0.9991 
Table 5-3 The slope, intercept and R
2
 values for the analyzed binary formulation HPMC 
and citric acid.  
The quantitative analysis (Table 5-3) of the kinetic profiles of the HPMC, API and water 
uptake in the binary formulation showed systematic changes within the slope values. 
Samples dissolved in 0.1 N HCl showed decreasing slope values for HPMC with increasing 
amount of HPMC in the sample, as we might expect considering the solubility of API in the 
acid. However the intercept values for API and HPMC are increasing. The intercept values 
give information about the time needed to observe the diffusion process occurring in the 
sample with a certain concentration. The water uptake profile values are increasing with the 
increasing concentration of HPMC in the sample. In the case of hyphenated experiments 
conducted in the pH 6.8 environment the slope values are decreasing with the increasing 
concentration of HPMC in the sample for all profiles. The intercept values are increasing in 
the case of HPMC and API. The obtained results showing the changes in the behaviour of 
the formulations depending on the dissolution media pH, what agrees with the results 
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obtained from dissolution testing. Also as observed the Figures 5-43 and 5-46 are 
suggesting swelling and further on dissolution process of HPMC. 
Along with the analysis of the infrared results the output of the UV detector was considered 
to broaden the obtained information.  
 
Fig 5-51. The output of UV reading for the formulation HA 80/20 and HA 60/40 during the 
dissolution testing in 0.1N HCl 
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Fig 5-52. The normalized kinetic profiles for formulations HA 80/20 and HA 60/40 and the 
absorbance units (AU) from the UV with reduction as voltage value for dissolution media 
(1-H2O) dissolved in 0.1N HCl 
 
Fig 5-53. The output of UV reading for formulations HA 80/20 and HA 60/40 dissolved in 
pH 6.8. 
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Fig 5-54. The normalized IR profiles for formulations HA 80/20 and HA 60/40 and output 
of the UV reading with the reduced values for dissolution media (1-H2O) dissolved in pH 
6.8.  
The profiles (Figs 5-51 to 5-54) obtained from UV detector showed significant differences 
when compared with the kinetic profiles obtained from the infrared spectroscopic analysis. 
The UV reading reflects the output from the top surface of the tablet, whereas the infrared 
spectra are collected from the bottom side of the tablet. The IR profiles showed a much 
faster ratio of drug dissolution than the UV kinetic profiles, as expected, since the PLS and 
NIR Imaging results obtained for solid tablets, showed the active substance had significant 
level of segregation on the top side of the tablet. In the case of hyphenated experiments this 
caused the differences in the UV measurements and the “dose dumping” effect. The UV 
profiles are very poor quality due to the low concentrations of the analyzed substances, 
irregular flow as the HPLC pump did not always deliver to the compaction cell as showed 
on the digital screen output and the non-conventional all the equipments set up.  
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5.3.3 Prediction of the possible components existing in the hyphenated samples using MCR 
data analysis  
IR data obtained from binary mixtures hyphenation experiments were analysed using 
MCR-ALS method. Three different MCR applications (Tauler, Hancewicz and PLS 
toolbox) were applied to allow an independent comparison of the calculated results.  The 
function Fast Non Negative Least Squares (F-nnls) deciding when elements (x) are less 
than zero was found to be the most appropriate way to avoid the rotational ambiguity; the 
other used parameters are discussed in the section 5.2.6. 
Validation of the method began with MCR analysis of three pure, dry component spectra of 
HPMC, active substance and citric acid. These spectra were collected using the FTIR-ATR 
instrument; the result achieved during MCR analysis was easily predicted. 
 
 
 
 
 
 169 
 
  Fig 5-55. Standards coloured spectra of four components: red-HPMC, green-water, blue-
active substance, dark blue-citric acid. 
The next step was to build a new model; the data matrix contained twenty-one spectra of 
dry samples, each one from a different formulation. The presence of characteristic bands 
from each component in a particular spectrum allows the determination of pure compounds 
from the mixed matrix data. Moreover concentration profiles show predicted (average) 
values for dry samples used in an investigated matrix.   
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Fig. 5-56. Spectra of mixed matrix contained four excipients spectra marked with different 
colours: red-water, green – HPMC, blue- citric acid, dark blue – active substance. 
 The obtained data were compared with the real values and shown for every substance 
separately on Fig 5-58 to 5-63 
 
Fig. 5.57. Comparison of drug spectra, blue colour- MCR prediction, red colour-infrared 
spectrum.  
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Fig. 5.58. Comparison of HPMC spectra, blue colour- MCR prediction, red colour-infrared 
spectrum.  
 
 
Fig. 5.59. Comparison of citric acid spectra, blue colour- MCR prediction, red colour-
infrared spectrum.  
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Fig 5-60. Concentration profiles of active substance, red colour - true values, blue colour -
values predicted in MCR analysis. 
 
Fig 5-61. Concentration profiles of HPMC, red colour - true values, blue colour -values 
predicted in MCR analysis. 
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Fig 5-64. Concentration profiles of citric acid, red colour - true values, blue colour -values 
predicted in MCR analysis. 
 
The output from the analysed data set (Fig 5-58 – Fig 5-64) provided spectra of dry 
excipients used in the formulations and also the concentration profiles which were 
compared to the real values used to prepare the mixtures. The predicted spectra showed 
high level of similarity to the real infrared spectra, and also the concentration values 
showed high resemblance to the accurate ones. The slightly larger intensity of the predicted 
spectra and values for concentrations are the effect of measurement noise and errors. The 
analysis of the validation model of the pure components and the binary systems solid 
dosage form spectra was conducted in the three applications simultaneously. All the 
methods; Hancewicz, Tauler and PLS Toolbox, provided similar results from the data set. 
Building the models from pure component spectra and validating the method was the 
critical step for the MCR analysis of the hydrated and hyphenated samples.  
Unfortunately at first spectra and concentration profiles of binary mixtures from hydration 
results obtained as MCR result didn’t show valuable information (Fig 5-65, 5-66). For 
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instance mostly on the component spectrum (from analysed binary or tertiary mixtures) 
bands coming out from the other compounds (included in a certain mixture) were 
significantly visible. Running analysis in three applications simultaneously didn’t bring 
expected solution. Although almost from each analysed sample results received from 
Hancewicz and PLS Toolbox were very similar to each other. 
The formulation HPMC and active substance HA50/50 
 
Fig 5.65 The MCR predicted spectra of formulation HA 50/50 
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Fig 5-66. The predicted concentration profiles from the formulations HA 50/50, dark blue-
water uptake, green-hydrated API, blue- API, red – HPMC, purple-hydrated HPMC.  
The difficulties with avoidance of rotational ambiguity and also the significant influence of 
dissolution media on the spectra of the samples caused the difficulties in getting any useful 
information from the data set. 
 
The next step in the extended MCR analysis took the approach of narrowing the spectral 
window which is a method used sometimes in the chemometrics data analysis. 
The example data is from the formulation of 60% HPMC and 40% active substance  
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a)              b) 
Fig 5.67 The predicted MCR spectra for the hydrated sample HA 60/40 a) the spectrum of 
hydrated HPMC, b) spectrum of water 
 
 
a)              b) 
Fig 5.68 The predicted MCR spectra for the hydrated sample HA 60/40 a) the spectrum of 
solid API, b) spectrum of hydrated API 
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a)              b) 
Fig 5.69 The predicted MCR spectra for the hydrated sample HA 60/40 a) the spectrum of 
solid HPMC, b) concentration profiles; green-water uptake, light blue-HPMC, dark blue-
API, purple- hydrated API, red-hydrated HPMC. 
The generated results (Fig 5-66-Fig 5.68), showed the predicted results for the analyzed 
sample. The solid substances spectra show high level similarity to the pure components 
spectra collected on the ATR. Also one could recognize the spectra of hydrated API and 
HPMC. It is possible to recognize the concentration profiles as well however the hydrated 
species present in the sample show quite noisy and irregular profiles and one could have 
difficulties to justify the obtained results. The narrowing spectral window in the range from 
2000-900 cm
-1
 improved the obtained results however to could achieve more informative 
data the further reduction of the spectral range would need to be applied. 
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5.4 Conclusions 
The dissolution of the binary system gave an indication about the behaviour of the 
formulation in the different dissolution media. The percentage reaching almost 100% of the 
dissolved drug was observed in the case of the dissolution of the sample in 0.1 N HCl, the 
experiments in the distilled water seemed to provide a high amount of dissolved drug as 
well in the system. As expected the slowest dissolution was observed in the case of pH 6.8 
phosphate buffer were after 12 h the amount of dissolved powder in the residue gel was still 
found, these observation confirm the pH dependence of the analyzed system.   
The analysis of the hydration experiments data showed faster dissolution and diffusion of 
the active substance and citric acid in distilled water when compared to the HPMC kinetic 
profile, which clearly showed the swelling process in the perturbed polymeric system by 
the dissolution media whilst the other excipients in the discussed binary systems reached 
equilibrium already. These results were also observed in the case of the hyphenated 
samples. These findings suggested the diffusion control as a possible dominant process of 
the drug release in the discussed binary formulations. However the hyphenation experiment 
confirmed also the pH–dependence already observed in the case of dissolution data of the 
discussed systems.  
The hyphenated samples data provided the information about behaviour of API and HPMC 
in a different dissolution media.  
Finally the MCR data analysis was successfully validated and applied to the solid samples 
spectra data matrix. The application provided the comparable spectral and concentration 
data with that collected on the FTIR equipment. The predicted spectra and concentration 
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profiles proved the further possibility of using this application in order to analyse the 
hydrated and hyphenated samples of the binary and tertiary mixtures.  
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6. Investigations of tertiary formulations in the 
solid state.  
The important stage of the formulation method development is addition of new excipients 
to the formulation. The additional substances in the formulation may improve the 
compressibility, hardness, drug release etc. of the tablets but simultaneously the 
manufacturing process of the solid dosage form using the direct compression method 
becomes more challenging. Considering that compression process has a number of stages 
like rearrangement of the particles in the compacted powder upon the applied force to 
minimize the presence of free spaces, deformation of the powder and finally the possible 
bonding of the compressed substances; the formulation excipients should show similar 
densities, particle size/distribution and morphologies to minimize the possible segregation 
within the samples[132, 152, 170].  
The physicochemical properties of the mixed powders together may increase the hardness 
of the tablet compared to the tablets made from pure excipients. Also the loading of the 
active substance in the formulation is one of the important factors in complex mixtures. The 
low concentration of active substance (up to 10% in the formulations) requires the particle 
size distribution of the powder giving the theoretical coefficients of variation less or equal 
to 1% to consider the mixture as homogeneous. The higher percentage of active substance 
in the formulation showed fewer difficulties with the API uniformity[132].     
This chapter discusses the tertiary formulation tablet compaction process and the possible 
interactions between the mixed powders. 
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6.1 Aims: 
 To manufacture the reproducible tablets in situ on the ATR crystal from tertiary 
formulations and investigate possible interactions of the components of the mixtures 
 To build the PLS model and predict the concentration values for the excipients of 
analyzed formulations 
 To conduct the analysis of the components distribution in the tablets   
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6.2 Materials and methods: 
6.2.1 Materials 
Materials used in this Chapter 2. 
6.2.2 Preparation of the mixtures  
Formulations were prepared according to proposed concentration values [%] (Table6-1).  
Tertiary formulation 
HPMC Active Cit 
Ac 
 HPMC Active Cit 
Ac 
 HPMC Active Cit Ac 
85 
75 
65 
55 
10 
20 
30 
40 
5 
5 
5 
5 
80 
70 
60 
50 
10 
20 
30 
40 
10 
10 
10 
10 
75 
65 
55 
45 
10 
20 
30 
40 
15 
15 
15 
15 
Table6-1. Concentrations [%] of tertiary formulations. 
 
The tertiary formulations were prepared by the method described in Section 3.2.2.2.  
The active substance was ground and passed through the sieve a 106 microns to match the 
particle size of API with the other excipients.  
 
6.2.3 Compaction process 
The compression of the tablets followed the procedure described in Section 3.2.4.2 and the 
parameters for the mixtures with particle size less than 106 microns detailed in Section 
3.2.4.3 
 
6.2.4 PLS analysis 
The predicted values of excipients concentration of the formulations were obtained as a 
result of the data analysis described in Section 3.2.5. 
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6.2.5 NIR Imaging  
Distribution of the components and image data analysis was conducted according to 
parameters listed in Section 3.2.6.  
The RGB analysis was continued in the Matlab R2007a and Octav software.   
Using the information provided by components concentration from different tablets a RGB 
image was constructed. The components in a RGB image are divided by colours, where red 
corresponds to API, green to Citric Acid and blue to HPMC. Areas in the tablet where a 
component concentration is higher than other components will be visible when the three 
colour are combined. A low concentration will approximate the colour to black while a 
higher to their respective red, green or blue. For comparison reasons the components 
concentration are scaled so that each component gets equal chance to be represented in the 
RGB image. The values are scaled into the range [0.0 1.0] using equation (eq.1) where 
minp is the minimum obtained value from component p and max p the maximum. 
 
 
RGB i p
values i p p
p p
,
, min
max min



   (eq.1) 
         
  
where i = 1, . . . , pixels and p is the component number 
As an example one could consider the concentration of component one (API) to be the 
highest and component two (Citric Acid) higher than component three (HPMC). In this 
case RGB(i, 1) > RGB(i, 2) > RGB(i, 3) which results in a color closer to red, or pure red in 
case RGB(i, 1) = 1.0 and RGB(i, 2) = RGB(i, 3) = 0.0. 
In case we have RGB(i, 2) > RGB(i, 1) > RGB(i, 3) then the final color will be closer to 
green, or pure green in case RGB(i, 2) = 1.0 and RGB(i, 1) =RGB(i, 3) = 0.0[171, 172]. 
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6.3 Results and discussion 
6.3.1 Investigations of possible interactions of the powders in the compacted tablet  
During the analysis of infrared spectra which provides the information on a molecular level 
the possible changes within the formulation excipients and active substance may be 
observed. The common interactions would involve the van der Waals force, hydrogen 
bonding or electron withdrawal by the neighbouring substituent, but also in a more 
complex structures it is more likely to find a new species in the mixed powders [69, 70, 
154].  
 
In this study spectra from the tertiary tablets were analyzed to investigate if any solid state 
interactions appeared or new polymorphic species emerged within the dry mixtures.  
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a) 
 
b) 
 
Fig. 6-1a),b). Infrared spectra of pure polymer, formulations of HPMC, active substance 
and 15% constant concentration value of citric acid, pure citric acid and active substance. 
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a) 
 
b) 
 
 
Fig. 6-2 a), b). Infrared spectra of pure polymer, formulations of HPMC, active substance 
and 10% constant concentration value of citric acid, pure citric acid and active substance. 
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a) 
 
b) 
 
Fig 6-3a), b). Infrared spectra of pure polymer, formulations of HPMC, active substance 
and 5% constant concentration value of citric acid, pure citric acid and active substance. 
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The tertiary formulation spectra (Figs 6-1 to 6-3) showed decreasing intensity of the strong 
characteristic band at~1100 cm
-1
 ν(CO) associated with the presence of HPMC in the 
samples with increasing concentrations of citric acid and API. The shape of the bands in 
spectra of mixtures are changing proportionally to the increasing amount of API and citric 
acid in the sample. In the region ~3570-3200 cm
-1
 the shape of ν(OH) is slightly modified 
by the presence of ν(OH)  band associated with citric acid where non bonded hydroxyl 
group forms narrow sub-maximum peak ~3500 cm
-1
 as well as OH group involved in 
hydrogen bonding stretching absorption at lower wavenumber within the discussed region. 
Increasing intensity of the API and citric acid bands proportionally to its concentration in 
the formulation is also observed in mixtures spectra at ~1750-1680 cm
-1
 region associated 
with the characteristic carbonyl group (C=O stretching frequency), and with presence of 
~1175-1045 cm
-1
 strong absorption ν(CO) and ~955-890 cm-1 region associated with OH 
deformation vibration of carboxyl group [31, 32].  
The relatively strong absorbance band in the region 1700-1650cm
-1
 is also associated with 
C=O stretching mode and  C=C skeletal benzene ring breathing modes in the region 1600-
1500cm
-1
 [49, 50].  
 
There is no evidence for shifts in the positions of bands which suggest that the powders 
were admixed and compacted with no chemical interactions taking place between the 
excipients.  
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6.3.2 PLS data analysis 
The concentration values of the excipients in the analyzed tablets were predicted using the 
PLS data analysis on the previously collected sample spectra from the tertiary formulations 
The samples selected for PLS data analysis were divided into two sets: the calibration set 
which consisted of 47 samples and the prediction set which consisted of 25 samples. 
Preprocessing of all the data was conducted and included path length correction and mean- 
centering. 
 
Tertiary formulations of HPMC, active substance and citric acid 
 
Fig. 6-4. Output of the PLS analysis showing the predicted versus calculated values for 
various tertiary mixtures of formulations HPMC, active substance and citric acid. 
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Mean and standard deviation for three components used in samples 
actual 
citric 
acid [%] 
mean 
citric acid 
[%] 
st dev 
citric acid 
actual 
API [%} 
mean 
API [%} 
st dev 
API 
actual 
HPMC 
[%] 
mean 
HPMC 
[%] 
st dev 
HPMC 
15 12.53 3.58 10 11.64 3.30 75 75.38 6.69 
15 14.26 1.31 20 21.31 0.67 65 64.20 1.11 
15 13.03 0.98 30 31.36 2.78 55 55.61 1.65 
15 13.54 1.55 40 37.91 2.03 45 48.59 0.87 
10 10.45 1.52 10 10.92 3.29 80 78.68 4.19 
10 11.25 2.62 20 21.02 1.67 70 67.86 3.29 
10 10.79 2.48 30 31.75 2.60 60 57.28 1.68 
10 10.30 1.85 40 37.95 2.84 50 51.87 3.04 
5 6.49 0.80 10 6.04 2.32 85 87.13 1.61 
5 5.93 0.71 20 20.94 2.14 75 72.86 2.55 
5 5.17 1.75 30 30.85 1.34 65 64.51 1.36 
5 6.21 2.80 40 39.31 2.86 55 54.57 0.47 
Table 6-2 Comparison of the mean and standard deviation calculated concentration with the 
actual concentration for the samples. 
 
The plots (Fig6-4) are showing the predicted concentration versus the actual one. The data 
fitted into the PLS linear model obtaining values of R
2
 coefficient > 0.9 for HPMC and 
slightly better for active substance, low value for citric acid ~0.71. However as the 
collected spectra shows a bit of the variability in the intensity values for the bands those 
differences in the data as well as possible measurement error will influence the final R
2
 
coefficient value.  
The predicted concentration values are showing variability compared to the actual 
concentration numbers. The mean and standard deviation values (Table 6-2)  
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are confirming slightly bigger variability between samples containing 15% of Citric acid 
compare to the samples with the 5% of the organic acid in the formulation.  
The results suggest higher level of heterogeneity of the tablets in the formulation HPMC, 
API and 15% of citric acid comparing with the mixtures made from the formulation with 
the constant concentration of citric acid 5%.  
Considering the lower level of reproducibility showed by the analyzed samples from the 
formulation consisting from HPMC, API and 15% of Citric acid compare to the tablets 
made from formulation containing constant concentration of citric acid 5% one could 
assume that the tablets may show different structural properties including possible 
segregation of the compounds and different compact compressibility, which may have 
affect on the drug dissolution from such a matrices. 
 
For all the tertiary mixtures the Press plot showed that 6 factors are required to describe 
variance in the data. Choosing less number of factors didn’t improve the analysis.  
 
Fig 6-5 Press plots showing the number of factors required for PLS analysis of the tertiary 
formulations HPMC, active substance and citric acid.  
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The PLS analysis provides predicted spectra of pure components which can be compared 
with the IR spectra collected from pure standard substances (Fig 6-6).  
 
 
Fig. 6-7 Predicted pure component spectra from PLS analysis compared with the IR spectra 
of pure substances: red colour -IR spectra, blue colour-the predicted PLS spectra. 
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wide variety of the bands intensity according to used variety of different concentrations is 
affecting the final intensity of the estimated spectra. Analyzing the position and shape of 
the particular bands, characteristic for the substances one could recognize the presence of 
HPMC in the analyzed samples as well as citric acid. Citric acid predicted spectrum shows 
strong presence of characteristic bands for this organic acid however the negative peak 
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associated with presence of the polymer in the sample in the region of 1100cm
-1
, which 
suggests co-linearity of the component concentrations. 
The API predicted spectrum contains the negative peaks associated with the presence of 
citric acid and HPMC in the sample. In fact one could have difficulties to recognize the 
presence of API in the sample based only on the information from the predicted spectra. 
There are no band shifts present in the predicted spectra. 
 
The principal components spectra (Fig 6-8) indicated the presence of characteristic bands 
for citric acid and HPMC. Although the PC’s spectra show a big resemblance to those two 
substances, there is very small amount bands associated with the active substance.  The 
PC3 shows the spectrum similar to the tablet spectrum collected after the compaction 
process.  
 
Fig. 6-8 Principal components predicted by the PLS analysis of HPMC and citric acid 
formulations.  
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6.3.3 NIR Imaging 
The complex systems consisting on three or more excipients are requiring the more 
advanced methods to analyze the components distribution within the tablet matrix. It 
becomes more critical to justify the level of heterogeneity in the analyzed system as the 
presence of any possible substance’s clusters or aggregates will dramatically influence the 
dissolution profiles of the tested formulation.  
The analyzed tertiary formulation results were applied to the further RGB analysis in order 
to achieve the information about content uniformity of the samples[84, 98].  
 
6.3.3.1 The tertiary formulations of HPMC, active substance and citric acid 
The image results are discussed on the examples of chosen formulations. 
Results show a set of six images from both sides of tablets prepared using blended 
powders. Samples were prepared as outlined in Chapter3. 
Formulation 45% HPMC 40% active substance 15% citric acid  
 
Fig 6-9. NIR images from top side of  tablets and prepared by blending mixture 
HAC45/40/15 of HPMC, active substance and citric acid and using torque 90 [cN.m] 
applied pressure. 
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Fig 6-10. NIR images from bottom side of tablets prepared by blending mixture 
HAC45/40/15 of HPMC, active substance and citric acid and using torque 90 [cN.m] 
applied pressure. 
 
Formulation 65% HPMC 20% active substance 15% citric acid  
 
Fig. 6-11. NIR images from top side of tablets prepared by blending mixture HAC65/20/15 
of HPMC, active substance and citric acid and using torque 90 [cN.m] applied pressure. 
 
Fig. 6-12. NIR images from bottom side of  tablets prepared by blending mixture 
HAC65/20/15 of HPMC, active substance and citric acid and using torque 90 [cN.m] 
applied pressure. 
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Formulation 50% HPMC 40% active substance 10% citric acid  
 
Fig. 6-13. NIR images from top side of tablets prepared by blending mixture HAC50/40/10 
of HPMC, active substance and citric acid and using torque 90 [cN.m] applied pressure. 
 
Fig. 6-14. NIR images from bottom side of tablets prepared by blending mixture 
HAC50/40/10 of HPMC, active substance and citric acid and using torque 90 [cN.m] 
applied pressure. 
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Formulation 70% HPMC 20% active substance 10% citric acid 
 
Fig. 6-15. NIR images from top side of tablets prepared by blending mixture HAC70/20/10 
of HPMC, active substance and citric acid and using torque 90 [cN.m] applied pressure. 
 
Fig. 6-16. NIR images from bottom side of  tablets prepared by blending mixture 
HAC70/20/10 of HPMC, active substance and citric acid and using torque 90 [cN.m] 
applied pressure. 
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Formulation 55% HPMC 40% active substance 5% citric acid 
 
Fig 6-17. NIR images from top side of tablets prepared by blending mixture HAC55/40/5 
of HPMC, active substance and citric acid and using torque 90 [cN.m] applied pressure. 
 
 
Fig 6-18. NIR images from bottom side of tablets prepared by blending mixture 
HAC55/40/5 of HPMC, active substance and citric acid and using torque 90 [cN.m] applied 
pressure. 
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         Formulation 75%HPMC 20%Active substance 5% Citric acid 
 
 
Fig 6-19. NIR images from top side of  tablets prepared by blending mixture HAC75/20/5 
of HPMC, active substance and citric acid and using torque 90 [cN.m] applied pressure. 
 
 
Fig 6-20. NIR images from bottom side of  tablets prepared by blending mixture 
HAC75/20/5 of HPMC, active substance and citric acid and using torque 90 [cN.m] applied 
pressure. 
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between the samples images collected from the top and bottom side of the tablets 
containing different concentration values of HPMC and API. The tablet images from the 
top surface show more uniform distribution of HPMC and active substance. However the 
citric acid aggregates can be found on the images of the bottom side of the tablets. The 
presence of aggregates/proper clusters of the acid is increasing on the tablet surface with 
decreasing concentration of active substance and increasing amount of HPMC within the 
formulation. In the case of formulation 75%HPMC20%active substance and 5% citric acid 
(Fig 6-20) the citric acid showed very low intensity values. The heterogeneous distribution 
of the citric acid was confirmed as well by the PLS analysis. Also the tablets from the top 
side images have recognizable regular shape whilst the bottom side of the tablet is 
deformed by the relaxation of the polymer during the tablet manufacturing process.  The 
further analysis of the samples confirms observed in the binary system the general trend of 
segregation of the compacted powders within the tablet; the distributed HPMC and API is 
observed along on the top side of the tablets showing high intensity values, whilst on the 
bottom side all the ingredients are present.  Also the roughness of the sample surface has an 
influence on the quality of the generated images, smoother sample surface the top side of 
the tablet gives a better quality image than the bottom side. 
 
Although from the collected images one could discuss about the distribution of the 
components particles it is impossible to relate the components intensity values to the 
concentration of the particular ingredient within the set of 6 tablets from the same 
concentration of the component and within different formulations and actually determine 
the uniformity of the tablet surface. The intensity values for the components show different 
scale for each of them (colorbar) as they are adjust according to the maximum and 
minimum values of the pure standard material absorption. 
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The outcome of the normalized NIR images analysis with the scale (0,1) for the 
components intensity values didn’t bring the expected results as the maxima for Citric acid 
and API are relatively low to compare with the HPMC intensity max value. 
The possible improvement of the data analysis could be obtained by performing the RGB 
analysis which would enable to show all the excipients of the tablet on the one image and 
give information about the homogeneity of the tablets.   
 
6.3.3.2 The RGB results of tertiary formulation of HPMC, active substance and citric acid 
bottom side 
The analysis was applied to the data collected from the bottom side of the tablets so the 
results could be compared to the FTIR data recorded from the same surface of the tablet. 
The colors associated with the substances: red-API, green-Citric acid, blue-HPMC.  
 
Fig. 6-21. Tablets general snapshot describing the number order given to the samples for 
performed RGB analysis.  
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45%HPMC 40%Active 15%Citric acid   
 
 
Fig. 6-22 The RGB analysis of the tablets from the formulation 45% HPMC 40% active 
substance 15% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
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65% HPMC 20% Active substance 15% Citric acid 
 
 
 
Fig. 6-23 The RGB analysis of the tablets from the formulation 65% HPMC 20% active 
substance 15% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
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50% HPMC 40% Active substance 10% Citric acid 
 
Fig. 6-24 The RGB analysis of the tablets from the formulation 50% HPMC 40% active 
substance 10% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
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70% HPMC 20% Active substance 10% Citric acid 
 
 
 
 
 
 
Fig. 6-25 The RGB analysis of the tablets from the formulation 70% HPMC 20% active 
substance 10% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
 
 
 
 206 
55% HPMC 40% Active substance 5% Citric acid 
 
 
 
 
 
 
 
Fig. 6-26 The RGB analysis of the tablets from the formulation 55% HPMC 40% active 
substance 5% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
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75% HPMC 20% Active substance 5% Citric acid 
 
 
 
 
 
Fig. 6-27 The RGB analysis of the tablets from the formulation 75% HPMC 20% active 
substance 5% Citric acid bottom side; order of the tablets according to the Fig 6-21.  
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The RGB output analysis (Figs 6-22 to 6-27) showed the distribution of the three 
components on the tablets surface [173, 174]. The maximum values of the intensity of the 
particular components are associated with the dark red, green and blue color, the low values 
intensity are showed as light red, blue, green respectively. The analysis of the generated 
images showed increasing heterogeneity of the samples with the increasing amount of 
HPMC in the formulation. Also increased amount of aggregates/ high concentration 
clusters of citric acid but also an API is visible on the surface of the tablets with the 
concentration of the API equal to 20% which one could have a difficulties to justify just 
based on the analysis of the previous images. The higher level of content uniformity is 
observed within the set of 6 tablets with the constant concentration of citric acid 5% for 
both 20% and 40% of active substance (Figs 6-21 to 22). The significant variability is 
visible in the case of formulation with constant concentration of 15% and 10% of citric 
acid. The formulation containing 15% of citric acid showed the significant amount of 
HPMC-blue colour on the tablet surface along with the presence of citric acid-green color 
whilst in the case of another formulation (10% of citric acid) the influence of API and citric 
acid is much more visible, the surfaces are heterogeneous within the same data sets. This 
data are confirming the observations based on the PLS data analysis. One could assume that 
the compressibility of the powders as well as their physical and chemical properties causing 
segregation of the components and the differences in the compacted structure of the tablet.       
 
The RGB analysis confirmed increased level of heterogeneity in the tertiary system 
compare to the binary formulations. The possible improvement of the tertiary systems 
could be achieved by using the particle size analyzer to confirm particle size of components 
during the preparation of the formulation to minimize the particle size differences between 
API, citric acid and HPMC.  
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6.4 Conclusions 
 
The solid dosage forms tertiary systems data analysis provided information about physico-
chemical properties of the prepared formulations. The FTIR analysis of the compacted 
mixtures showed the presence of the characteristic bands for the analyzed substances 
however no changes in a position of the bands where observed. There is no indication of 
the hydrogen bonding between the mixed excipients in the spectra. The spectrum of the 
mixed substances showed overlapping peaks of the characterized excipients what confirms 
the need of developing more advanced data analysis in the case of future hydration and 
hyphenation experiments. 
  
The conducted PLS data analysis showed variability in the reproducibility of the samples in 
the case of Citric acid and these results were also compatible with the chemical imaging 
data. The HPMC and active substance obtained results from PLS showed higher level of 
variance in the tablets compared to the binary systems. Chemical maps of the HPMC 
distribution confirmed the more heterogeneous surface with increasing concentration of this 
component in comparison with API distribution. The most uniform formulation are the 
mixtures containing the constant concentration of the citric acid equal 5%, which was also 
confirmed by the PLS data analysis.   
The images of the top side of the tablets showed the general tendency of active substance to 
segregation on that part of the tablet as all analyzed samples indicated higher intensity for 
the API particles than on the bottom side.  
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7. Investigations of the tertiary formulations in a 
dissolution media. 
Drug dissolution of the more complex systems involves many interactions of polymer 
matrix, drug substances and added excipients. There are several mathematical models used 
to describe the drug dissolution process from the swellable matrices. However every system 
depending on the physico-chemical properties of the components shows different 
dissolution process characteristic. The chemical reactions, hydration of the sample, 
protonation/deprotonation, the emergence of new species, possible hydrogen bonding and 
solvation have influence on the final drug release result.  
 
Standard dissolution testing provides the final values of the dissolved drug in the 
experiment and it also shows the percentage of the released substance in a certain amount 
of time. However this technique is not able to provide any information about the 
formulation on the molecular level [151, 153]. 
 
In this chapter the solid tablets from the tertiary formulation compacted on the diamond 
ATR were introduced to the dissolution media and the possible interactions are within the 
samples discussed.  
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7.1 Aims: 
 To investigate the drug release from tertiary formulation in a different pH media  
 To monitor the hydration and hyphenation experiments and develop information 
about the formulation behaviour in static and dynamic conditions 
 To apply the MCR data analysis on the hydrated and hyphenated samples data and 
investigate the possible changes within the analyzed systems. 
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7.2 Materials and methods: 
7.2.1 Materials 
Materials used in this chapter are listed in Appendix A 
7.2.2 The analyzed formulation [%] 
 
HPMC Active Cit Ac   HPMC Active Cit Ac 
85 
75 
65 
55 
10 
20 
30 
40 
5 
5 
5 
5 
75 
65 
55 
45 
10 
20 
30 
40 
15 
15 
15 
15 
                
Table7-1. Concentrations of tertiary formulations 
The tertiary formulations were prepared by the method described in Section 3.2.2.2.  
The active substance was passed through the sieve to match a particle size of API with the 
other excipients.  
 
7.2.3 Dissolution testing 
The dissolution experiments procedure is discussed in Chapter 5, section 5.2.3. 
 
7.2.4 Hydration and Hyphenation experiments 
The hydration and hyphenation experiments method is discussed in Chapter 5, section 
5.2.5. 
 
7.2.5 MCR data analysis  
The parameters used for the MCR data analysis are described in Chapter 5 section 5.2.6 
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7.3 Results and discussion 
 
7.3.1 Hydration experiments 
The results of hydration experiments will be discussed based on the example of 65% 
HPMC 20% Active substance 15% citric acid mixture. 
 
 
Fig 7-1   Spectra from the hydrated sample HAC 65/20/15 collected during 12 h experiment 
 
Results obtained from hydration experiment tertiary formulation of HPMC and active 
substance and citric acid (Fig. 7-1) showed increased intensity of the band ν(O-H) 3006-
3699 cm
-1
 associated with water up take and decreased band ν(C-O) 980-1160 cm-1 as a 
result of the polymer swelling process. Spectra collected from this formulation showed 
increasing impact of dissolution media in the sample with time. The formulations spectra 
showed a decreasing relatively strong absorbance band of API in the region 1700-1650cm
-1
 
associated with C=O stretching mode and  C=C skeletal benzene ring breathing modes in 
the region 1600-1500 cm
-1 
[49, 50]. Also the 2700-2400 cm
-1
 delocalized N…H bonding is 
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no longer presence in the fully hydrated sample. The increasing concentration of the 
dissolved active from the polymer matrix caused the reduction of the intensity of these 
bands. The citric acid in the sample showed changes in the intensity and shape of the 
decreasing bands in the regions 1700-1500 cm
-1
 ν(C=O) and 1050-1400 cm-1 ν(C-O).  
 
In order to obtain quantitative information the generated profiles were normalized and 
plotted against square root time. 
 
 
Fig 7-2. Normalized kinetic profiles of the hydrated sample formulation HAC65/20/15 
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Fig 7-3. Normalized profiles of the water uptake 
 
 
Fig 7-4. Normalized profiles of the API 
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Fig 7-5. Normalized profiles of the citric acid 
 
 
Fig 7-6. Normalized profiles of the HPMC 
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the matrix faster whilst the polymer still continues the swelling process. The citric acid 
dissolves and diffuses out slower from the polymer matrix than API, however the citric acid 
profile shows the rapid diffusion rates as expected considering the results from NIR 
Imaging which showed the aggregates of the citric acid and heterogeneous distribution of 
that component.   The HPMC profiles showed the initial hydration of the polymer up to 180 
min and then followed by the swelling process. 
The slope is the vertical distance divided by the horizontal distance between any two data 
points on the line, this represents the rate of change along the regression line.  
There is a systematic change in the slope value (Table 7-2) for polymer and API, which 
increases with increasing concentration of HPMC in the sample. Water uptake slope values  
mainly decrease with increasing concentration of HPMC in the sample, which confirms the 
suggested diffusion control process in the analyzed system. Citric acid appears to be 
independent of concentration. There is similar tendency between the HPMC and water 
uptake profiles compared to the binary formulations observed in Chapter 5. For both binary 
and tertiary systems the water uptake profile slope value decreases with increasing 
concentration of HPMC in the sample. However citric acid and API appears to be 
independent from the HPMC concentration for both systems. 
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Kinetic profiles quantitative data 
Formulation  Water 
uptake 
Citric acid API HPMC 
HAC 
45/40/15 
Slope 0.0164 -0.0197 -0.0218 -0.0236 
Intercept[s] 3931 13608 14648 20449 
R^2 0.9965 0.9954 0.9959 0.9872 
HAC 
55/30/15 
Slope 0.0176 -0.0201 -0.0212 -0.0202 
Intercept[s] 3445 12444 11960 19081 
R^2 0.999 0.9971 0.9986 0.9979 
HAC 
65/20/15 
Slope 0.015 -0.024 -0.0212 -0.0154 
Intercept[s] 3760 12157 11960 20759 
R^2 0.9928 0.9982 0.9986 0.9842 
HAC 
75/10/15 
Slope 0.0143 -0.0178 -0.019 -0.0145 
Intercept[s] 3912 15411 13940 25840 
R^2 0.9946 0.9968 0.9924 0.9907 
Table 7-2 The slope, intercept and R
2
 values for the analyzed binary formulation HPMC, 
citric acid and active substance 
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7.3.2 Effect of different pH dissolution media on the drug release from tertiary 
formulations.  
The dissolution experiments for formulation HPMC, active substance and constant 
concentration of citric acid 5% were conducted in distilled water, pH 6.8 phosphate buffer 
and 0.1 N HCl; pH 1.5.  
The formulation HPMC, active substance and constant concentration of citric acid 5% was 
chosen for dissolution and hyphenation experiments since the data collected from the solid 
dosage form (PLS data analysis and NIR Imaging) suggested the lowest level of 
heterogeneity compared to the other tertiary systems.  
 
 
 
Fig. 7-8 Mean dissolution profiles for formulations of HPMC, citric acid and active 
substance, the 200 mg tablets where placed in pH 6.8 phosphate buffer and 0.1N HCl as the 
dissolution media. 
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The dissolution profiles of tertiary mixtures (Fig 7-8) showed a significant difference 
between the samples with the drug loading 40% and 20% tested in pH 6.8 and 0.1N HCl. 
Quicker release and higher percentage of dissolved API was observed in the case of the 
samples with the API concentration 40%. The addition of citric acid to the formulation 
improved the dissolution of the samples dissolved in pH 6.8 when compared to its absence 
(Fig 5-5). The percentage of the dissolved drug is similar to that dissolved in 0.1 N HCl. 
The obtained results clearly show the pH dependence of the samples. As one could expect 
the citric acid in the polymer matrix builds up the so called “microenvironmental pH” 
which allowes for drug release independently of the pH of surrounding media. In the result 
both samples with drug concentration 40% dissolved with similar drug percentage.  
 
 
7.3.3 Hyphenation experiments 
The hyphenation experiments are discussed based on the mixture 55% HPMC 40% active 
substance and 5% of citric acid. 
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Fig 7-9. Normalized profiles of the formulation HPMC, API and citric acid. 
 
 
Fig 7-10. Normalized profiles of water uptake. 
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Fig 7-11. Normalized profiles of Citric acid. 
 
 
Fig 7-12. Normalized profiles of API. 
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Fig 7-13. Normalized profiles of HPMC 
 
 
Fig 7-14. Normalized profiles of formulation HPMC, API, citric acid. 
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Fig 7-15. Normalized profiles of HPMC. 
 
 
Fig 7-16. Normalized profiles of API. 
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Fig 7-17. Normalized profiles of Citric acid. 
 
Fig 7-15. Normalized profiles of HPMC. 
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Kinetic profiles quantitative data 
Formulation  Water 
uptake 
Citric acid API HPMC 
HAC 
55/40/5 in 
0.1 N HCl 
Slope 0.0127 -0.0203 -0.0217 -0.0166 
Intercept[s] 1148 10783 11336 15188 
R^2 0.9965 0.9954 0.9959 0.9872 
HAC 
75/20/5 
In 0.1 N HCl 
Slope 0.0133 -0.0201 -0.0185 -0.015 
Intercept[s] 2125 1427 15556 25658 
R^2 0.999 0.9971 0.9986 0.9979 
HAC 
55/40/5  
in pH 6.8  
Slope 0.0176 -0.0194 -0.0237 -0.0122 
Intercept[s] 5778 10149 9243 18486 
R^2 0.9928 0.9982 0.9986 0.9842 
HAC 
75/20/5 
In pH 6.8 
Slope 0.0141 -0.0159 -0.0113 -0.0145 
Intercept[s] 2540 12805 23400 25840 
R^2 0.9946 0.9968 0.9924 0.9907 
Table 7-3 The slope, intercept and R
2
 values for the analyzed binary formulation HPMC, 
citric acid and active substance 
The analysis of the generated profiles for the tertiary formulations (Fig 7-9 to 7-15) showed 
that with ingress of water into the tablet matrix the dissolved active substance diffuses out 
from the matrix whilst the polymer still continues the swelling process. The citric acid 
dissolves and diffuses out from the polymer matrix and API, in the case of 0.1N HCl 
dissolution media. The HPMC profiles showed the initial hydration of the polymer 
followed by the swelling process as indicated by an initial increase in integrated intensity 
followed by its decrease. 
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The quantitative analysis (Table 7-3) of the kinetic profiles of the HPMC, API, citric acid 
and water uptake in the tertiary formulations showed systematic changes within the slope 
values. Samples dissolved in 0.1N HCl showed increasing slope values for HPMC and 
water uptake, with an increasing amount of HPMC in the sample, as we might expect 
considering acid dissolution media.  
In the case of hyphenated experiments conducted in the pH 6.8 environment the slope 
values increases with increasing concentration of HPMC in the sample for API and citric 
acid profiles. The water uptake profile slope value decreases with increasing concentration 
of HPMC in the sample.   
The intercept values increase in the case of citric acid, HPMC and API for the samples 
dissolved in pH 6.8, as HPMC concentration is increased and for API and HPMC from 
samples dissolved in 0.1N HCl. The obtained results show the onset of the changes in the 
behaviour of the formulations depending on the dissolution media pH, which agrees with 
the results obtained from dissolution testing.  
Comparing the hyphenation experiments of the binary and tertiary system; in the case of 
samples dissolved in 0.1 N HCl the API and HPMC slope values decreases with increasing 
concentration of HPMC, in the case of pH 6.8 this trend is observed for HPMC profile 
slope values, no regular tendency is present in the case of API.  
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Along with the analysis of the infrared results the output of the UV detector was considered 
to broaden the information obtained.  
 
Fig.7-16. The normalized kinetic profiles of formulation HAC 55/40/5 and HAC 75/20/5 
and output of the UV reading with the reduced values for dissolution media (1-H2O) 
dissolved in 0.1 N HCl 
 
Fig.7-17. The normalized kinetic profiles of formulation HAC 55/40/5 and HAC 75/20/5 
and output of the UV reading with the reduced values for dissolution media (1-H2O) 
dissolved in pH 6.8  
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The profiles (Fig 7-16 to 7-17) obtained from UV detector showed significant differences 
when compared with the kinetic profiles obtained from the infrared spectroscopic analysis.  
The UV profiles are similar to those of the binary systems since they showed much faster 
rate of drug dissolution than the respective profiles generated from infrared data. This is 
anticipated considering the PLS and NIR Imaging results obtained for solid tablets. The 
active substance showed the level of segregation on the top side of the tablet, which in the 
case of hyphenated experiments causes the differences in the UV measurements. The UV 
output shows the active substance dissolved quickly in a very short period of time and 
presumably the first measurements of UV detector are connected with the active substance 
segregated on the top side of the tablet. 
The UV profiles are very poor quality due to the low concentrations of the analyzed 
substances, irregular flow as the HPLC pump and non-conventional equipments set up. 
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7.3.3 MCR data analysis 
The results of the tertiary formulation hyphenation experiments will be discussed on the 
example of the sample HAC 55/40/5 in pH 6.8  
 
 
Fig 7-18 Predicted spectrum of water                        Fig 7-19 Predicted spectrum of API 
 
Fig 7-19 Predicted spectrum of hydrated          Fig 7-20 Predicted spectrum of hydrated API 
citric acid 
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Fig 7-21 Predicted spectrum of hydrated HPMC     Fig 7-22 Predicted spectrum of HPMC 
 
 
Fig 7-23 Predicted spectrum of solid API.                             Fig 7-24 Predicted                  
concentration profiles;                                                                                                               
green colour – water uptake, grey-API, 
blue-HPMC, light green – citric acid, 
red-hydrated API, dark blue-hydrated 
HPMC, puple-hydrated citric acid 
The generated results (Figs 7-18 to 7-24), showed the predicted spectral results (the axis X 
intensity values versus the wavenumber axis Y) and concentration profiles (the axis X 
intensity values versus the time (mins) axis Y the analyzed sample). Analyzing the 
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generated spectra one could easily recognize the spectrum of water and solid API. 
However, the rest of the spectra contain bands coming from other excipients of the 
formulation. In addition Fig 7-19 showed the negative spectrum which has band associated 
with all components in the formulation. 
The MCR analysis is supposed to predict, based on the data matrix, the possible 
components of the mixture. 
In the case of this formulation, the prediction should show the presence of solid excipients, 
water and hydrated forms of excipients. However the analysed data set didn’t show 
expected results as the spectral information was very noisy and contained a mixture of 
bands characteristic for excipients.  
The narrowing spectral window in the range from 2000-900 cm
-1
 improved the data 
analysis however to achieve more informative data and avoid the rotational ambiguity the 
further reduction of the spectral range would need to be applied. 
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7.4 Conclusions 
The dissolution experiments performed on the tertiary system provided information about 
the behaviour of the formulation in the different dissolution media. Almost 100% of the 
dissolved drug was observed in the case of the dissolution of the samples in 0.1N HCl or 
pH 6.8. As expected the impact of citric acid on the dissolution results was observed and 
confirmed the pH dependence of the analyzed system.   
The analysis of the hydration experiments data showed the dissolution and diffusion of the 
active substance and citric acid, whilst the HPMC kinetic profile showed the continuous 
swelling process of the perturbed polymeric system by the dissolution media. These results 
were also observed in the case of the hyphenated samples. These findings suggested the 
diffusion control as a possible dominant process of the drug release in the formulations. 
However the hyphenation experiment confirmed also the pH–dependence already observed 
in the case of dissolution data of the discussed systems.  
The hyphenated samples data provided the information about behaviour of API, citric acid 
and HPMC in a different dissolution media.  
Finally the MCR data analysis was applied to the hyphenated samples spectra data matrix. 
The predicted spectra and concentration profiles proved the further need of development of 
data analysis as the obtained results were not very good quality in order to compare the 
hydrated and hyphenated samples of tertiary mixtures. However, the heterogeneity of the 
compacted samples may be the underlying problem due to the poor results. 
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8. Conclusions: 
The optimization of the parameters for a reproducible manufacturing process of the 
formulation was conducted testing the effect of different mixing procedures, (manual 
shaking, tumble blending and grinding) and variability of particle size on the uniformity of 
the formulations determined by the FTIR-ATR with PLS data analysis and NIR Imaging. 
The binary formulations of HPMC and Citric acid showed that the samples without 
matching particle size and mixing procedure had a high degree of heterogeneity. The 
presence of component aggregates on the surfaces of the analyzed samples determined by 
NIR imaging, PLS data analysis and also Infrared spectra. It was observed that the particle 
size had a significant impact on experimental data in terms of reproducibility and 
heterogeneity of the samples. 
The optimal tablet reproducibility and homogeneity of components has been achieved by 
controlling the particle size of the substances used for mixture preparation. The samples 
were compacted in situ on the ATR crystal in a compaction cell which proved to be a 
successful tool in a small scale tablet manufacturing process. The variation in the intensity 
of FTIR-ATR spectra, PLS analysis and NIR imaging confirmed homogeneity of the binary 
formulation and higher level of heterogeneity in the case of tertiary formulations. 
 
The dissolution of the tertiary system gave an indication about the behaviour of the 
formulations in the different dissolution media. The percentage reaching almost 100% of 
the dissolved drug was observed in the case of the dissolution of the samples in 0.1 N HCl 
and pH 6.8 respectively. As expected the impact of citric acid on the dissolution results was 
observed what confirmed the pH dependence of the analyzed system. 
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The analysis of the hydration experiments data showed the faster dissolution and diffusion 
of the active substance and citric acid in both systems compare to the HPMC kinetic profile 
which clearly showed the continues swelling process whilst the other excipients reached 
equilibrium already. These results were also observed in the case of the hyphenated 
samples.  
The diffusion control is a possible dominant process of the drug release in the analyzed 
formulations. Also the hyphenation experiments confirmed the pH dependence already 
observed in the case of the dissolution data of the discussed systems. 
Finally the MCR data analysis was applied to the solid sample spectra and hyphenated 
samples spectra data matrix. The predicted spectra and concentration profiles from the 
hydrated and hyphenated experiments proved the further need of development of data 
analysis. 
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8.2 Further work 
 
The studies of drug controlled release from hydrophilic matrices were limited to the binary 
and tertiary mixtures. Further development of the formulation would require adding more 
excipients to build new compositions and investigate the behaviour of the multi-component 
tablets. However, hydration and hyphenation experiments of the binary and tertiary 
mixtures could be still challenging if we could reconsider few significant factors having 
impact on the further development of the project. 
 
8.2.1 Reconstruction of the compaction cell 
 
Originally, the compaction cell was made from brass, as this material was supposed to be 
ideal for drugs which are salts chemically, and it could ensure a lack of reactivity of the 
compound with the compaction cell. However, if during the experiment the medium used 
for dissolution of the sample was 0.1 n HCl, after several experiments, the built up of the 
passivation layer in the water channels was visible. In a result a breakage of this layer leads 
to the corrosion of the internal channels in the compaction cell and surroundings of the 
sample.   
For further static hydration and hyphenation experiments, it would be necessary to make 
the compaction cell from Teflon, as this material is resistant to pH changes, and could 
prevent from any possible leakages of the medium in the sample die/ screw area from the 
compaction cell during the experiment. Another advantage of a new compaction cell (Fig8-
1) would be a presence of another connection on the top of the cell with the water channels 
in order to minimize the amount of time needed to fill the cell with the required medium. 
 237 
 
Fig 8-1. The design of the compaction cell.  
 
8.2.2 ATR-FTIR Imaging as a main technique of further investigation. 
 
The FTIR-ATR application used to conduct the hydration and hyphenation experiments 
achieved spectral information about the analysed systems on a molecular level.  
However spectroscopic imaging techniques can provide more detailed data about the 
investigated samples. In the last few years, Kazarian’s group reported about the possible 
applications of FTIR Imaging for pharmaceutical and biomaterial samples [168, 175-177] 
and also some work on monitoring of polymer dissolution using FTIR Imaging was carried 
out  by Ribar [178]. The examples of investigations carried on pharmaceutical samples 
involved drug release and tablet dissolution [147, 148, 168, 175, 179], water sorption in 
pharmaceutical substances under controlled humidity [175] and quite a lot of work done on 
polymers diffusion or dissolution in solvents. ATR-FTIR Imaging is a powerful tool that 
could improve the results of the experiment, giving additional spatial information from the 
samples. In comparison with normal transmission FTIR microscopy (resolution 40-50 
micrometers) such an imaging system is able to achieve a very high spatial resolution down 
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to few micrometers as well as the acquisition of the images and data analysis is much faster 
than in case of FTIR microscopy where measurement of the reasonable area of the sample 
and further data analysis of obtained map of the surface will take hours [168, 176].  
 
8.2.3 Future experiments 
 
Further work should involve further optimization of the particle size of the excipients using 
particle size analyzer and in the next stage the hydration and hyphenation experiments on 
binary and tertiary mixtures using FTIR Imaging technique.  
Kazarian’s group published results of hydration experiments conducted in a compaction 
cell on binary mixture HPMC and drug. However the experiment was lacking the 
continuous dynamic conditions as the liquid (distilled water) was provided by a syringe, the 
investigated tablets covered only half surface of the ATR crystal what makes an additional 
requirement of very high level homogeneity of the tablet to could approve the spectroscopic 
results.  The data were calculated for the whole amount of the sample [148].  
The innovative approach of this project would involve using the dynamic conditions in the 
experiment ( HPLC pump) what could ensured the constant flow of the liquid, changing pH 
of dissolution media from 1.5 (0,01 N HCl) to 6.8 phosphate buffer could give more 
understanding of the behaviour of the investigated formulation. The samples would be 
compacted directly in situ on the ATR crystal and cover the surface of the internal 
reflectance element. The data collected from the investigated tablet would be further 
analysed and the obtained information about the spatial distribution of excpients in contact 
with dissolution media could provide an important basis for understanding of the 
mechanism of drug release in analysed system and building a mathematical model for the 
optimisation of controlled drug delivery. Further on the research could continue on 
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mixtures with addition of other excipients like lubricant i.e magnesium stearate, filler i.e. 
avicel to develop and optimise the controlled release formulation. 
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